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ABSTRACT
My doctoral research begun with the function assignment to two domains of fusion
protein BT4699, from Bacteriodes thetaiotaomicron, BF1314 from Bacteriodes fragilis and
PG1653 from Porphyromonas gingivalis. BT4699, however, is insoluble, so its orthologue
BF1314 and PG1653 were prepared and studied. The fusion proteins consist of a domain that
belong to a large family of phosphatases known as Haloacid Dehalogenase (HAD) superfamily,
and a domain belong to the hotdog-fold thioesterase superfamily. The genes encoding the fusion
proteins located at an operon that encoding enzymes involved in the menaquinone biosynthetic
pathway. So we assumed that the thioesterase domain is connected to the biosynthesis of
menaquinone, which sever as a crucial role in the anaerobic bacteria respiratory chain. While the
HAD domain is involved in hydrolysis of pyrophosphate produced by MenA in the lower
segment of the pathway. The thioesterase domain was predicted to catalyze the hydrolysis of
1,4-dihydroxyl-2-napthoyl-CoA (DHNA-CoA) to 1,4-dihydroxyl-2-napthoate (DHNA) as the
precursor of menaquinone synthesis.
To study the function of thioesterase domain, the putative substrate 1,4-dihydroxy
naphthoyl-CoA was prepared by chemienzymatic strategy. The structure was confirmed by H
NMR and mass spectrum. HPLC analysis indicated that DHNP-CoA is very unstable, which
vii

could be self-hydrolyzed within 16 hrs at pH=7.5. By using a combination of techniques like
steady-state kinetics, HPLC, and NMR, the function of thioesterase domain of the fusion protein
were investigated. Steady-state kinetics studies indicated that PG1653 has high activity over
DHNP-CoA. HPLC and H-NMR proved the formation of hydrolyzed products. The high
specificity of BF1314 and PG1653 over DHNP-CoA testified the function of thioesterase
domain.
While the function of HAD domain is not that as we assumed. It didn’t even show any
activity towards pyrophosphate. PG1653 fusion protein did not have any phosphatase activity
due to the mutation of Asp to Phe, which is a key catalytic residue of HAD phosphatase. The
other fusion protein BF1314 just showed very weak activities towards a few phosphate
substrates. Both truncated HAD domain and thioesterase domain were also prepared to
investigate the function of HAD domain. Size exclusion chromatography was used to examine
the effect of native structure on the functions of both HAD domain and thioesterase domain. The
results indicated that the HAD domain may serve as an oligmerization domain that help the
tetramerization of the thioesterase domain as an active thioesterase tetramer. The structure
supportive role of the HAD domain disabled its phosphatase activity.
The HAD domain homologue, BT3352, shares 47% identity with fusion protein BT4699.
This high level of identity suggests that these two HADs are related by gene duplication. One
gene copy must have fused with the thioesterase domain and took on a structural function that
supports the thioesterase function while losing its catalytic function. The other copy may carry
on the function of the original phosphatase. BT3352 exhibited good sugar phosphatase activities,
and erythrose 4-phosphate turned out to be its physiological substrate. By comparing with its
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homologue yidA from E. coli, which may play a house keeping role in the galactonate
degradation pathway, we hypothesized that BT3352 may also play house keeping role in
likewise pathway.
Bioinformatic analysis suggests that the 4 gene cluster might encode a partial β-oxidation
pathway in Pseudomonas aeruginosa, which supported the pathway with seven other gene
clusters. The target gene cluster contain two putative β-oxidation pathway enzymes, acyl-CoA
dehydrogenase (PA5187), 3-hydroxy-acyl-CoA dehydrogenase (PA5188), a putative ironcontaining alcohol dehydrogenase (PA5186) and a putative hotdog-fold thioesterase (PA5185).
Substrate screen results indicated that PA5187 target C4-C15 fatty acyl-CoA, while PA5188
showed good activity towards C4-C10 and peak at 3-hydroxyhexanoyl-CoA. The hotdog-fold
thioesterase exhibited narrow substrate specificities, which is good for C2-C4 acyl-CoA
thioeters, and propionyl-CoA is the best substrate. Based on these results we conclude that This
is a fatty acid oxidation pathway which augments the central fatty acid degradation pathway
found in all bacteria. While the structure of the liganded PA5185 is needed to understand how it
selects for the small substrates.
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CHAPTER 1: GENERAL BACKGROUND INFORMATION

1.1 Hotdog-fold Thioesterase superfamily

(b)

(a)

(c)

Figure 1.1 a). Ribbon presentation of E coli. ydii crystal structure, b) The hotdog
dimmer structure of ydii and c) Schematic diagram of ydii secondary structure topology.

Thioesters play a central role in the cells where they participate in metabolism,
membrane synthesis, signal transduction, and gene regulation (1). The carboxylic acid
components of biological thioesters are metabolites of varied size, shape, and polarity.
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They are converted to thioesters by ligases for the purpose of solubility, transport,
signaling, or activation for reaction in biosynthetic or biodegradation pathways. The
naturally occurring thiols include coenzyme A (CoA), glutathione, the pantetheine unit of
the holo-acyl carrier protein (ACP), and the cysteine residue of a protein. Thioesters are
reverted to the thiol and carboxylic acid components by hydrolysis catalyzed by
thioesterases. Thioesterases have primarily evolved within the /β-fold hydrolase enzyme
superfamily (2) and the hotdog-fold enzyme superfamily (3). The conserved fold of the
hotdog fold superfamily proteins consists of a five-stranded antiparallel β-sheet wrapped
around an elongated -helix. This topology is reminiscent of a hotdog “bun” wrapping
around a “sausage”, hence the name hotdog fold (4).
The “hot-dog” fold superfamily of enzymes is a large group of structurally
related enzymes with diverse biochemical functions. Family members are found in
eukaryotes, bacteria and archaea wherein there are involved in a range of cellular
processes (3). The “hot-dog” fold was first observed in the structure of E. coli. βhydroxydecanoyl thioester dehydratase (4). The hotdog domain consists of a fivestranded anti-parallel β-sheet wrapped about an elongated α-helix, reminiscent of a
hotdog in a bun (Figure 1.1a and 1.1c). Two hotdog subunits associate to form the
functional unit (Figure 1.1b), an extended β-sheet structure with two active-site clefts
located at the respective ends of the subunit-subunit interface (Figure 1.1b).
Two backbone segments frame the catalytic scaffold of the active site,
contributing catalytic and substrate-binding groups. One segment is the N-terminus of the
elongated α-helix and its connecting loop from one subunit (subunit A), and the other is
the center segment of the elongated α-helix on the opposing subunit (subunit B) (colored
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green and blue, respectively in Figure 1.2). The backbone amide NH of the α-helix Nterminus residue of subunit A engages in hydrogen-bond formation with the substrate
thioester C=O, thereby orienting and polarizing the C=O for nucleophilic attack. A
carboxylate residue is used as a general base or nucleophilic catalyst for the hydrolysis
reaction (Figure 1.2). It is positioned at either of two locations in the active site scaffold.
The location divides the hotdog thioesterase family into two "catalytic motif"
subfamilies. For one group (type AA, Figure 1.2), the catalytic carboxylate residue (Asp
17) is located on the same subunit as the polarizing α-helix N-terminus, where it is
positioned on the loop that enters the α-helix N-terminus (Tyr 24). For group type AB,
the polarizing α-helix N-terminus is located on one subunit (Figure 1.2, His 65) and the
catalytic carboxylate residue Glu73 (Figure 1.2) is found on the α-helix of the opposing
subunit. The thioesterase domain of the HAD-thioesterase fusion proteins is type AB (59).

Figure 1.2 (Left) the catalytic scaffold type AB and type AA represented by the
Arthrobacter and Pseudomonas 4-hydroxbenzoyl-CoA thioesterases, respectively (4hydroxybenzoylthioester unit of the truncated 4-hydydroxybenzoyl-CoA substrate ligand
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is colored grey. (Right) The hot dog thioesterase dimer with the locations of the catalytic
residues indicated by red dots.

1.2 Catalytic Mechanism of Hotdog-fold Thioesterases
The catalytic carboxylate residue can function in base or nucleophilic catalysis
(Figure 1.3 A). In the former, a water molecule is deprotonated by the catalytic
carboxylate as it attacks the thioester C=O. If a tetrahedral intermediate is formed, the
proton may hop from oxygen to sulfur prior to expulsion of the CoA. Alternatively, a
general acid or electrophilic residue might assist in thiolate departure, although the need
for thiolate protonation is not indicated by the results of earlier studies of solution
hydrolysis of thioesters.

Figure 1.3 The A) nucleophilic catalysis and, B) general base catalysis in the hotdog
thioesterase.
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In nucleophilic catalysis, the carboxylate attacks the thioester C=O, resulting in
the transient formation of a tetrahedral oxyanion that subsequently generates an
unsymmetrical anhydride intermediate. The anhydride undergoes nucleophilic attack at
the C=O by a water molecule, from a position that conforms to the stereoelectronic
requirements for carbonyl addition (10). An active site residue may engage in hydrogen
bond formation with the water molecule for positioning, and possibly deprotonation,
required for its nucleophilic attack at one of the two C=Os of the unsymmetrical
anhydride.

1.3 Biological Functions of Thioesterases
1.3.1 Aromatic Compounds Degradation Pathway
Some bacterial thioesterases function in the degradation pathways of certain
aromatic compounds. The 4-chlorobenzoate (4-CBA) dehalogenation pathway (Figure
1.4) that converts the common 4-CBA to the metabolite 4-hydoxybenzoate (4-HBA).
Several bacterial strains (viz. Pseudomonas sp. CBS3, Alcaligenes sp. NTP-1 and
Arthrobacter sp. strain SU) harboring pathway have been isolated from soil and sludge,
based on their ability to utilize 4-CBA as a sole source of carbon. In each of these
bacteria, 4-CBA is first converted to 4-HBA, and 4-HBA can be further degraded via the
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Figure 1.4 4-Chlorobenzoate Dehalogenation Pathway

the ortho or meta-aromatic ring oxidation pathways, which funnel into the -ketoadipate
pathway. The acetyl-CoA and succinyl-CoA products enter the TCA cycle for energy
generation.

The 4-CBA dehalogenation pathway of Pseudomonas sp. strain CBS3 is the best
characterized. The genes encoding this pathway in Pseudomonas sp. strain CBS3 are
chromosome borne. In 1986, a 9.5 kb chromosomal DNA fragment from this strain that
encoded the dehalogenation pathway enzymes was cloned into the cosmid vector
pPSA843 (11). Selective expression of the dehalogenation pathway genes revealed three
polypeptides of molecular weight of 57, 30 and 16 kDa as possible components of the
dehalogenation system. Recombinant protein production of the pathway components
showed that three enzymes, i.e., 4-CBA CoA ligase, 4-CBA-CoA dehalogenase and 4HBA-CoA thioesterase function in a sequential three-step reaction pathway (12). The 4CBA:CoA ligase utilizes Mg (II), ATP and coenzyme A (CoA) to form the 4-CBA-CoA
thioester. The 4-CBA-CoA dehalogenase catalyzes a novel aromatic substitution reaction
involving the replacement of the chloride with a hydroxyl group (13). The thioesterase of
this dehalogenation pathway is responsible for the ensuing hydrolysis of 4-HBA-CoA to
generate 4-HBA and CoA (12).

1.3.2 Menaquinone Biosynthesis Pathway.
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In prokaryotes, ubiquinone (aka coenzyme Q) and menaquinone (MK) (aka
vitamin K) are lipid-soluble molecules that shuttle electrons between membrane-bound
protein complexes in the electron transport chain (14, 15). For example, Escherichia coli,
a facultative anaerobe, utilizes ubiquinone under aerobic conditions, yet uses MK (MK-8)
when grown anaerobically (15). In contrast, vertebrates use MK as a cofactor for certain
carboxylases involved in blood coagulation, bone metabolism, tissue calcification and
cell cycle regulation (16). In mammals, the electron transport chain is located in the inner
mitochondrial membrane, where ubiquinone is used instead of menaquinone.
Menaquione can also act as a signaling molecule that regulates the transcription of genes
involved in its own metabolism (17). The principal structural variations within the two
main classes of quinones occur from the length of the isoprenoid chain. In mitochondria
the ubiquinone has a side chain of 10 isoprene units (CoQ-10), while in E. coli the
ubiquinone has a side chain of 8 isoprene units (CoQ-8) (18, 19).
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Figure 1.5 The bacterial menaquinone biosynthesis pathway

The biosynthesis of menaquinone has mainly been studied in E. coli (15, 16).
Chorismate (Figure 1.5), derived from the shikimate pathway, is initially converted into
isochorismate by MenF, MenD, MenH, and MenC to O-succinylbenzoate (OSB), the
succinyl chain is activated by ligation with CoA catalyzed by MenE, and then cyclized,
producing 1,4 dihydroxy 2-naphthoyl-CoA (DHNA-CoA). Subsequently, a specific CoA
thioesterase removes CoA and frees the carboxyl group of 1,4 dihydroxy 2-naphthoate
(DHNA) and allows its conjugation to the polyisoprenyl chain for anchoring into
biological membranes.

1.3.3 Fatty Acid Biosynthesis Pathway.

Figure 1.6 The fatty acid biosynthesis reaction cycle initiates with transfer of the acetyl
moiety to the KS via an ACP-bound intermediate (initiation). The malonyl thioester is
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similarly transferred to an ACP (substrate loading) and then condensed with the KSbound acyl chain (chain extension). The resulting β-ketone is then reduced and
dehydrated, yielding a saturated acyl chain (β-carbon processing) that is delivered to the
KS, initiating the next cycle. After seven cycles, the 16-carbon acyl chain, palmitate, is
released by thioesterase (chain termination) (20).
Fatty acids are essential components of all biological membranes and also
represent an important form of energy storage in both animals and plants. Their
biosynthesis occurs universally. The synthesis of fatty acids de novo is achieved by
sequential condensation of two-carbon units derived initially from acetyl-CoA. In
eukaryotes, this process is mediated by fatty acid synthase. This large enzyme complex is
comprised of two multifunctional polypeptide chains, each containing seven discrete
functional domains, juxtaposed head-to-tail such that two separate centers for fatty acid
assembly are formed at the subunit interface. In prokaryotes, the fatty acid synthetic
pathway is the same, however the enzymes that catalyze the reaction steps are separate
entities (e.g., ketoacyl-ACP synthase, ketoreductase, dehydrase and reductase) (Figure
1.6).
The FAS thioesterase (thioesterase I) is the chain-terminating enzyme in both
bacterial and human fatty acid syntheses. It releases the fatty acids by hydrolyzing the
thioester bond in newly synthesized fatty acyl-ACP. The thioesterase in FAS has a
marked specificity for long-chain substrates, exhibiting a 10-fold preference for C16 over
C14 straight-chain acyl-thioesters (21). This specificity dictates that C-16 straight-chain
saturated fatty acid is the major product of de novo fatty acid biogenesis in most
biological systems.
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In nature, fatty acids having shorter chain lengths (C12 and C14) are also
abundant. The modification of the chain length of the FAS product requires the
participation of a second chain-terminating thioesterase, thioesterase II, which is not
associated with the FAS and which has preference for acyl thioesters of medium chain
length. Thioesterase II is a discrete monofunctional, monomeric protein of 29 kDa that
exhibits hydrolase activity toward medium chain-length acyl thioesters (22). Thioesterase
II can access the growing acyl chain on the 4’-phosphopantetheine of the FAS to
hydrolyze the thioester bond, thus releasing the medium chain-length saturated fatty acids
that are typically 8 to 14 carbon atoms in length. It is believed that the interactions
between the multi-component FAS and thioesterase II is dynamic rather that static and
that substantial conformation changes accompany catalysis (23).

1.3.4 Thioesterases in mediation of intracellular lipid metabolism.
The abilities of acyl-CoA thioesterases to catalyze the hydrolysis of acyl-CoAs to
free fatty acid and coenzyme A (CoASH) provide the potential to regulate intracellular
levels of acyl-CoAs, free fatty acids and CoASH. These thioesterases have been observed
in almost all cellular compartments, including the endoplasmic reticulum, cytosol,
mitochondria and peroxisome. Recently, several thioesterases functioning in the different
cellular compartments were purified, and their encoding genes cloned. These
thioesterases are varied in their molecular weight and substrate specificity.
In the cytosol of eukaryote cells, acyl-CoAs and free fatty acids may regulate
gene transcription via nuclear receptors. One such example is nuclear receptor HNF-4α
that activates or inhibits transcription depending on the presence or absence of acyl-CoA
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(24). Cytosolic thioesterase I (CTE-I) has a suggested role in controlling levels of acylCoA/fatty acids in the cytosol by hydrolyzing acyl-CoA. Thus, the activity of this
thioesterase has a direct impact on gene transcription.
In mitochondria, where the β-oxidation occurs, high levels of CoA are required to
maintain high metabolic capacity. The mitochondria acyl-CoA thioesterases may play
important roles in maintaining sufficient CoA levels for optimal mitochondrial function.

1.3.5 Microbial polyketide natural product biosynthesis pathways

Figure 1.7 Biosynthesis of 6-deoxyerythronolide B

Thioesterase domains are also found in polyketide (PKS) and nonribosomal
peptide synthetases (NRPS) which produce the polyketide and the cyclic peptide core of
pharmacologically important compounds, including the antibiotics erythromycin,
rifamycin, vancomycin, the immunosuppressive agent cyclosporin A and the anti-cancer
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agent epithilone. The NRPS and PKS consist of modules of linked protein domains.
Natural product acyl chains grow from an N-terminal initiation enzyme module through a
series of elongation modules, one for each monomer added; then a C-terminal
termination module releases the full acyl chain from its covalent thioester linkage (Figure
1.6). Each module has at least three protein domains: 1) a catalytic domain for selection
and loading of the monomer, 2) the pantetheinylated acyl carrier domain, and 3) a
catalytic domain that mediates chain extension, consisting of C-C bond formation to a βketo thioester (a thioclaisen condensation) for PKS and C-N amide bond formation for
NRPS. Based on the domain content of the PKS or NRPS, we can predict the backbone
structures of the encoded natural products. Release of the full length acyl/peptidyl chains
is mediated by thioesterases, some of which catalyze hydrolysis while others catalyze
regiospecific macrocyclization. Tailoring of PK and NRP chains, by acylation, alkylation,
glycosylation and oxidoreduction, occurs both during tethered chain growth and after
thioesterase-mediated release (25).
The biosynthesis of the polyketide core of erythromycin A, 6-deoxyerythronolide
B (6-dEB), has provided the paradigm for understanding the structure and function of the
PKSs that are responsible for assembling complex polyketides (Figure 1.7). The 6eoxyerythronolide B synthase (DEBS), which catalyzes the formation of 6-dEB, consists
of three large subunits, DEBS1, DEBS2 and DEBS3, each containing two modules and
above 300 kD in size. There are 2 domains in the N-terminal loading module, responsible
for priming the synthase with a proprionate starter unit, and 26 domains in the six
extender modules. Each extender module contains at least three essential domains: a
ketosynthase (KS), an acyl transferase (AT) and an acyl carrier protein (ACP). The AT
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domain selects the appropriate carbon extender unit and transfers the units from acylCoA onto the phosphopantetheine arm of ACP. The KS domain accepts the polyketide
chain from the previous module and catalyzes the chain elongation reaction by adding an
ACP-bound extender unit through decarboxylative condensation. After the extender unit
is added, it can be further processed by optional tailoring domains, including
ketoreductases (KRs), dehydratases (DHs), and enoyl reductases (ERs), to yield a
hydroxyl, enoyl, or methylene group at the beta-position. Finally, the thioesterase (TE)
domain that located at the C-terminus of DEBS module 6 promotes the macrocyclization
event, which releases the final product, 6-dEB (26).

1.4 Haloalkanoate Dehalogenase (HAD) Enzyme Superfamily
The haloalkanoate dehalogenase (HAD) enzyme superfamily is a large,
ubiquitous enzyme superfamily. It contains more than 19,000 unique sequences which
are distributed among all three superkingdoms of life. Numerous members are found in
each organism; there are 28 in Escherichia coli, 30 in Mycobacterium tuberculosis, 169
in Arabidopsis thaliana, and 183 in Homo sapiens. The HAD superfamily, named after
the archetypal enzyme haloacid dehalogenase (27), includes enzymes catalyzing carbon
or phosphoryl group transfer reactions on a diverse range of substrates, using an active
site aspartate in nucleophilic catalysis. The majority of the enzymes in this superfamily
are involved in phosphoryl transfer. These are the phosphate monoester hydrolases
(phosphatases)

or

phosphoanhydride

hydrolases

P-type

phosphonoacetaldehyde hydrolase (phosphonatase) and phosphomutases.
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(ATPases),

All cellular organisms synthesize and degrade nucleic acids, phospholipids, and
phosphorylated proteins in addition to a vast number of primary and secondary
organophosphate metabolites. Consequently a large number of phosphohydrolases and
phosphotransferases have evolved and they have done so within a relatively small set of
superfamilies (28, 29).
Members of the HAD superfamily have assumed numerous disparate biological
functions, which vary in their degree of essentiality to the cell. A central question
regarding this family is how the catalytic platform has been adapted through evolution to
act on a wide range of substrates, a process which has termed the “evolutionary
exploration of substrate space” (30). The availability of numerous crystal structures of
representatives belonging to diverse branches of the HAD superfamily has facilitated the
study of the diversification of structure and function within the HAD superfamily.

1.4.1 Structural and Functional Aspects of the HAD Superfamily
Except the four highly conserved catalytic motifs, the level of sequence divergence
among members of the HAD enzyme superfamily is quite high (sequence identity <15%)
(31). With the development of sequencing techniques, the number of sequenced genes
grows geometrically. More and more genes are found to be misannotated especially in
HAD superfamily. The question of conservation of backbone fold and active-site
diversification within the family is best addressed through comparison of members
catalyzing different chemistries, by comparing the folds, active-site scaffolds, and
catalytic mechanisms of HAD members, with the ultimate goal of gaining insight into the
evolution of catalysis within the HAD enzyme superfamily.
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1.4.2

Structural of the HAD Superfamily Catalytic Domain
The catalytic domain of the HAD superfamily is a three layered α/β sandwich

comprised of repeating β-α units which adopt the topology typical of the Rossmannoid
class of α/β folds. The central sheet is parallel and is typically comprised of at least five
strands in a β5, β4, β1, β2, β3 order (Figure 1.8).

Figure 1.8 Topology diagrams of domains representative of the major divisions of
Rossmann-like folds with catalytic residues.

Sequence comparisons have shown that practically all members of the HAD
superfamily contain four highly conserved sequence motifs (32) (Figure 1.9a and
Figure1.10). Sequence motif I corresponds to strand β1 and the DxD signature is present
at the end of this strand. The carboxylate group of the first Asp and the backbone C=O of
the second Asp coordinate the Mg2+ cofactor (Figure 1.9b). Additionally, the first Asp in
motif I acts as the nucleophile that forms an aspartyl-phosphate intermediate during
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catalysis (33). In phosphatase and phosphomutase members of the superfamily the second
acidic residue acts as a general acid-base. It binds and protonates the substrate leaving
group in the first step and deprotonates the nucleophile of the second step (33). In the
ATPases, the occurrence of a threonine at this position allows for a reduced rate of
aspartyl phosphate hydrolysis, which may allow for the time lag necessary for the
consequent conformational change. In the phosphonatases, there is an alanine instead of
the second aspartate, which is consistent with the unique role played by the enamine
intermediate (formed with the insert domain) as a general base catalyst in aspartyl
phosphate hydrolysis.
Motif II corresponds to the β2 strand, which is characterized by a highly conserved
threonine or a serine at its end. Motif III contains a conserved lysine that occurs near the
N terminus of the helix located upstream of β4. Motif II and motif III contribute to the
stability of the reaction intermediates of the hydrolysis reaction. The lysine in motif III is
reminiscent of the basic residues termed arginine fingers that stabilize the negative charge
on reaction intermediates in many other phosphohydrolases, particularly those of the Ploop NTPase fold (34). It is likely that the Lys residues play a similar role even in the
HAD hydrolases. An analysis of the available structures shows that the lysine in motif III
may occur in either of two structural contexts in different HAD hydrolases. In the P-type
ATPases, acid phosphatases, phosphoserine phosphatases and the Cof phosphatases the
lysine is incorporated into the helix immediately preceding strand S4. However, in all
other HAD hydrolases it emerges from the loop immediately prior to the helix. On
account of this difference in the secondary structure context of the lysine, motif III is
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poorly conserved relative to the other motifs. Motif IV maps to strand β4 and the
conserved acidic residues located at its end.

a)

b)

Figure 1.9. a). The conserved core domain loops shown in the typical superfamily
members, the Haloalkanoic Acid Dehalogenase from Pseudomonas sp. Loop 1 is colored
in red, Loop 2 is colored in green, Loop 3 is colored in blue and Loop 4 is colored in
yellow. b). Chemdraw depiction of the active site.

The terminal acidic residues of motif IV typically exhibit one of three basic
signatures: DD, GDxxxD, or GDxxxxD. These acidic residues, along with those in motif
I, are required for coordinating the Mg ion in the active site (31, 35, and 36). Motif I to
motif IV are spatially arranged around a single “binding cleft” at the C-terminal end of
the strands of the central sheet that forms the active site of the HAD superfamily. This
binding cleft is partly covered by the β-hairpin flap occurring after β1. An additional
insert occurring between the two strands of the flap or in the region immediately after β3,
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provides extensive shielding of the active site from solvent as is required for catalytic
activity. These inserts, termed caps, often contain residues which contribute to substrate
specificity or assume auxiliary catalytic functions. The cap domains play a central role in
the reactions catalyzed by most HAD hydrolases (37-39).

Loop1
Loop2
Loop3
Loop4
12 16
126
160
185186 190
IFDWAGTT17....STTGYTRE131....GRPYPWM165... ...IKVG DTVSDMKEGR194
AFDLYGTL15....ILSNGSPQ120....YKPDNRV156... ...LFVA SNAWDATGAP186
VFDAYGTL12....ILSNGAPD117....FKPHPDS135... ...LFVS SNGFDVGGAK163
LFDFDSTL16....VVSGGFDI104....AKGEILE149... ...VAVG DGANDISMFK176
CFDVDSTV24....LISGGFRS103....GKGKVIK163... ...IMIG DGATDMEACP188
AFDLDGVL14....IVTNNWLD128....IKPEPQI165... ...VFLD DFGSNLKPAR194
ITDVDGVL19....VLSGRDPI63.....EKETACF89.... ...YIGD DSVDLPAFAA117
IFDVDGTL170...VVSGRESG216....VKEEIFW263... ...LAID DRTQVVEXWR287
LVDMDGVL46....ICTSPIKM135....DKTVVSA170... ...LLID DRPDITGAEP185
LFDLDGVI13....LASASKNG119....SKPAPDI148... ...IGLE DSQAGIQAIK176
CSDKTGTL356...MITGDNKG640....HKSKIVE689... ...MTGD GVNDAPALKK713
ILDWAGTT16....SCSGYPAA130....GRPGPWM166...
ILDWAGTV20....SCSGYPRV135....GRPWPAQ171...
VFDLDGVL14....ILTNTWLD112....VKPEPQI165...
LFDVDGTL13....VASTTSLP120....KKPSPDI156...
VTDIEGTT13....VYSSGSVA130....AKREAQS164...
LLDMDGVM16....VVTGRPRK129.....KPSPEP161...
LFDLDGTI17....IVTSGSPY123....GKPDPEG156...
LFDVDGTI44....VATSGTRD141....GKPHPEP175...
IFDMDGTL14....VVSGSKYE148....SKSIALS194...
ILDKTGTI430...MVTGDNQR587....EKANYVE617...
CSDKTGTL392...MVTGDHPI633....QKLVIVE714...

...VKVD
...VKVD
...VFLD
...VALE
...LFLS
...M.VG
...VVFE
...VVFE
...FFGD
...MVGD
...VTGD

DAAPGISEGL196
DTWPGILEGR201
DIGANLKPAR196
DSLNGLRAAK185
DIHQELQAAE193
DTVDDIIAGR190
DAPVGIKAGK192
DAPAGIAAGK211
NTREGGNDFE217
GINDAPALRL741
GVNDSPALKK738

PHN Bc
HAD Pyl
HAD Xa
PSP Mj
PSP Hs
sEH Murine
YrbI Hi
PNK T4 phage
dNT-2 Hs
BPGM Ll
ATP Rabbit
PHN St
PHN Pa
sEH Hs
PGP Rs
EP Ko
IGPD Pp
DGPP Sc
G3P Sc
PMM Bb
ATP Eh
ATP Hs

Figure 1.10 Sequence alignment of HAD core domain. In each loop, the residues
identified by computer analysis of the primary sequence are colored black and the
residues identified by structure-function analysis are colored dark blue (loops 1 and 4,
will be discussed next), in loop 4, the metal ion pair is underlined. The upper part of the
figure is for the sequences with known X-ray structures.

Despite the low overall sequence identity between the dehalogenase, phosphonatase
and phosphatase, their folds are remarkably similar, particularly within the core domain
(Figure 1.9a). The similarity in the overall folds together with the high sequence identity
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within the conserved catalytic motifs (37) supports the hypothesis that they evolved by
divergent evolution from a common progenitor. In the case of convergent evolution to a
common protein structure and common chemistry, it would be expected that there would
be no significant sequence identity and that the catalytic residues would be provided by
different loops and therefore by different regions of the polypeptide chain. This is not the
case in the HAD members where the conserved core domain supports a common activesite scaffold that consists of four loops located at topological switch points of the core
domain.

1.4.3

Role of the Cap Domain in the Catalytic Mechanism of the HAD Superfamily

Figure 1.11 The HADSF can be divided into subfamilies by the topology and location of
the cap domain. C1 members have a helical bundle inserted between motif I and II, C2a
and C2b members have one of two different domains inserted between motif II and
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III and C0 have no cap (insertion site of cap between motifs shown as primary sequence
diagram).

The most notable sequence inserts observed in the HAD superfamily are the caps,
which, despite their diversity, can be classified into three categories: 1) type C0 members
are structurally the simplest representatives of the HAD superfamily. They have only
small inserts in either of the two points of cap insertion. 2) type C1 members are defined
as HADs that contain inserts occurring in the middle of the β-hairpin of the flap motif,
and fold into a structural unit distinct from the core domain. 3) The type C2 members are
defined as HADs that contain inserts occurring in the linker immediately after strand S3
(C2a or C2b) (Figure 1.10). Most members of the HAD superfamily have either a C1 cap
or a C2 type cap, although in few cases proteins may simultaneously possess both C1 and
C2 caps (40).
Key aspects of the HAD catalytic mechanism that emerged from the reported
family analysis are (40): 1) the alternation between open and close states and 2) a
preliminary reaction favored by solvent exclusion and a subsequent step favored by
extensive solvent contact. The principal features of the core domain responsible for this
process are the squiggle and the flap. The squiggle, being close to a helical conformation,
appears to be a structure that can be alternatively tightly or loosely wound. This
differential winding in turn induces a movement in the flap immediately juxtaposed to the
active site and alternatively results in the closed and open states (Figure 1.11). The strict
conservation of the squiggle and the flap across the HAD superfamily suggests that they
are likely to be part of a universal essential functional feature of this superfamily (37, 39).
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The conformational changes in the squiggle and flap comprise the minimal apparatus for
solvent exclusion and access at the active site of these enzymes. Given this minimal state,
natural selection appears to have favored the emergence of cap modules as they made the
process of solvent exclusion and acyl phosphate formation more efficient. In addition to
aiding the basic catalytic mechanism the emergence of diverse caps also provided a
means of substrate recognition by supplying new surfaces for interaction with substrates,
which was not afforded by the ancestral active site alone (37, 38).

Figure 1.12 Space filling model of BT4131 in the open conformation (left), and close
conformation (right) (41).

1.4.4 Evolution of the HAD Superfamily
The higher-order structural relationships of the HAD fold suggest that it first
emerged as a part of the expansion of the phosphoesterase or Mg2+ chelating class of
21

Rossmannoid folds (40). The emergence of the squiggle and flap motifs might have
allowed for a rudimentary solvent exclusion mechanism that allowed the HAD
superfamily to acquire a catalytic mechanism based on the concomitant formation of an
acyl phosphate intermediate (40). HAD enzymes do not participate directly in DNA
replication and protein/RNA synthesis. The ancestral HAD phosphatase, like the
ancestral version of the Rossmannoid folds, might have acted on nucleotides (40). This is
suggested by the observation that nucleotide substrates are encountered in all the major
branches of HAD superfamily including members of the earliest branching C0
assemblage, specifically the bifunctional polynucleotide kinase/phosphatase. The early
branching C0 members appears to have specialized in large substrates such as proteins
and nucleic acids, which precluded the need for large solvent-excluding caps (42). The
emergence of various caps appears to have provided an additional structurally variable
interaction module that allowed different representatives of HAD superfamily to accept a
diverse range of substrates, typically small molecules.

1.4.5 Function and Structure in PSP Families of HAD C1 Subfamily
The PSP family is characterized is actually a hybrid of the C1 and C2 cap domain
families. The family prototype phosphoserine phosphatase (PSP) catalyzes the
dephosphorylation of L-3-phosphoserine in the biosynthetic pathway of serine (43, 44).
PSP active-site residues are located at the interface between the two domains. The active
site can be divided into two sub-sites: a phosphate-binding site and a serine-binding site.
Lys 144, Asn 170, Gly 100, and a magnesium ion in the phosphate-binding site form a
cationic cavity that facilitates the transfer of the phosphate group. All of the phosphate-
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binding residues are from three conserved sequence motifs in the core domain. The
specificity and orientation of the serine group of L-phosphoserine are achieved through
interactions with residues from the helical cap domain: Glu 20 and Arg 56 form Hbonded salt-bridges with the amino group and the carboxyl group of L-phosphoserine,
respectively, while Met 43 and Phe 49 form van der Waals contacts with the serine group
(45).

1.4.6 Function and structure of C2b subfamily protein BT3352 and yidA

Figure 1.12 Bacterial pathogens (46)

The HAD superfamily type C2 phosphatases are prevalent in secondary metabolic
pathways, and thus provide an excellent test case for in vivo function assignments and
they provide an opportunity to explore the unusual but apparent functional redundancy
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within the HAD superfamily. That is, in members of this subfamily (e.g., the NagD gene
product and Bacteriodes thetaiotaomicron BT4131) there appears to be low level (kcat =
1-26 s-1; kcat/Km = 1 x 103 M-1 s-1) of overlapping activities with a number of common
sugar substrates, including D-glucose 6-phosphate, D-fructose 6-phosphate, D-gluconate
6-phosphate, D-arabinose 5-phosphate, and N-acetyl-glucoseamine-6-phosphate (41). In
order to understand this phenomenon, the substrate range of each target enzyme must be
identified. Also it is likely that the combined application of the substrate docking and
library screening plus gene knock-out phenotyping will be required for in vivo function
determination.

1.5 Goals of Doctoral Research
My doctoral research initially focused on determining the physiological substrates and
structural determinants of substrate recognition in two HAD superfamily members and
two hotdog-fold superfamily members. The first target was selected because it is a
Rosetta protein comprised of a HAD superfamily domain and a hotdog-fold superfamily
domain. A possible function for the thioesterase domain was suggested by the inclusion
of the encoding gene in a gene cluster that encodes the menaquinone pathway in certain
Bacteriodetes species. My initial goal was to demonstrate the function of the thioesterase
in this pathway and then develop and test hypotheses for the function of the tethered
HAD superfamily domain. In order to define the structural determinants for the
recognition of the respective physiological substrates, I would supply purified protein to
our collaborator Professor Karen Allen (of Boston University) for crystallization and Xray structure determination. The structure obtained would be used to direct my site24

directed mutagenesis based analysis of the structural determinants of substrate
recognition. Because the fusion protein did not crystallize, I identified a pair of single
protein orthologues for structural analysis. The structure of the HAD superfamily member
BT3352 was determined, however the thioesterase did not crystallize. Nevertheless, I
demonstrated that it, and the thioesterase domain of the fusion protein, function in the
menaquinone pathway by catalyzing the hydrolysis of the pathway intermediate 1,4dihydroxynapthoyl-CoA. Substrate specificity analysis of the HAD member BT3352
revealed that it is a promiscuous phosphatase which prefers small (C4 and C5) sugar
phosphates. The structural basis for substrate recognition was determined through the
kinetic analysis of site-directed mutants.
The second part of my doctoral research focused on identifying the chemical steps
of a pathway in Pseudomonas aeruginosa which employs a hotdog-fold family member
(PA5185) to catalyze one of the steps. The pathway enzymes are encoded by an operon
that contains genes of unknown function. The objective was to use bioinformations to
identify possible chemical functions of the encoded enzymes and then test these functions
using a focused substrate activity screen. By linking the chemical reaction catalyzed and
the substrate specificities of each of the pathway enzymes I hoped to define a new
metabolic pathway.
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Chapter 2 The HAD Phosphatase: Hotdog-fold Thioesterase Rossetta Protein of the
Menaquinone (Vitamin K2) Pathway

2.1 Menaquinone Biosynthesis

Scheme 2.1 Oxidized and reduced forms of Menaquinone.

Menaquinone is a lipid-soluble molecule that serves important biological
functions. In humans and animals, it is a vitamin (K2) that has to be acquired from the
diet or bacteria in the gut (1). This substance is crucial in blood clotting through its
involvement in the γ-carboxylation of glutamate residues (2), bone metabolism, and (3)
calcification of arteries and other soft tissues (4). In bacteria, menaquinone is an electrontransporting molecule where it serves as the only electron carrier in the respiratory chain
of aerobic Gram-positive bacteria and most anaerobic bacteria (Scheme 2.1) (1). It is also
needed in the respiration of facultative bacteria, such as Escherichia coli, during
anaerobic growth (1). It is essential for the survival of bacteria and, as a consequence of
its absence in humans and animals, the menaquinone biosynthesis pathway has been a
potential target for the development of new antibiotics.
The biosynthesis of menaquinone in E. coli (5,) Bacillus subtilis (6) and
Mycobacterium phlei (7) shown in Fig. 1 has been carefully investigated. The E. coli
menaquinone contains a 40-carbon isoprene chain (MK-8). In the pathway, chorismate,
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PPi

MenG

MenA

ATP, CoA

AMP, PPi

Figure 2.1 The bacterial menaquinone biosynthesis pathway

derived from the shikimate pathway, is initially converted to isochorismate by MenF, an
isochorismate synthase (8), and then to 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1carboxylate (SHCHC) by the action of the thiamin-dependent enzyme MenD (9, 10).
SHCHC is then dehydrated by MenC (a member of the enolase superfamily) to give the
aromatic compound O-succinylbenzoate (11). O-Succinylbenzoate (OSB) is converted to
OSB-CoA by MenE (12), which is a member of acyl-CoA ligase superfamily (13). The
naphthoquinol skeleton of DHN is generated via a cyclization reaction catalyzed by 1,4dihydroxynaphthoyl-CoA synthase, MenB (14, 15). The 1,4-dihydroxynaphthoyl-CoA is
hydrolyzed to DHN by an uncharacterized thioesterase. Finally, in the last two steps of
the pathway, menaquinone is generated from DHN by the action of MenA, which
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catalyzes a prenylation process, and by MenG, an S-adenosylmethionine (SAM)dependent methyl transferase. Polyprenylpyrophosphate required by MenA is synthesized
via a non-mevalonate isoprenoid pathway (16).
The human internal cavity is colonized by a variety of bacteria that establish longterm symbiotic relationships with the host. Most predominant are the Bacteriodes species
thetaiotamicron, vulgatus, distasonis and fragilis, which inhabit the gut and
Porphyromonas gingivalis, which inhabits the mouth. The menaquinone operon of
Bacteriodes (depicted in Figure 2.1) that encodes enzymes that catalyze the conversion of
chorismate to DHN-CoA also includes a gene that encodes a two-domain protein of
unknown function (P. gingivalis ExPasy accession Q7MU91, B. caccae ExPasy
accession A5ZGV9, B. thetaiotamicron ExPasy accession Q89YN2, B. ovatus ExPasy
accession A7M602, B. uniformis ExPasy accession A7VAE9, B. fragilis ExPasy
accession

Q64WR2

and

Q5LFS7,

B.

stercoris

ExPasy

accession

B0NN98,

Parabacteriodes merdae ExPasy accession A7AG7, P. distasonis ExPasy accession
A6LB33). An alignment of the two-domain proteins of the Bacteriodes species is shown
in Figure 2.2B. Presumably, the two domain protein arose by gene fusion. In bacteria the
genes that encode proteins that function together in a common biological process are
often organized in a gene cluster. A mutation event that connects the two genes results in
a “Rosetta protein”, which typically possesses the functions of the two ancestral proteins.
The N–terminal domain (residue 1-265 using the numbering from the P.
gingivalis protein sequence) of the two domain protein belongs to the haloacid
dehalogenase superfamily (HADSF) and the C-terminal domain (residues 290-407)
belongs to the hotdog fold superfamily.
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Q7MU91
A5ZGV9
Q89YN2
A7M602
A7VAE9
Q64WR2
Q5LFS7
B0NN98
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Figure 2.2 The gene map of the menaquinone biosynthetic pathway operon. B.
An alignment of sequences of HAD-thioesterase fusion proteins.

The intervening sequence (residues 266-289) might serve as a solvated linker that
connects the HADSF domain to the hotdog fold domain. The HADSF is comprised of
phosphotransferases, a majority of which are phosphatases. The hotdog fold superfamily
is comprised primarily of acyl-CoA and acyl-carrier protein thioesterases.
Although the menaquinone pathway in E. coli. has been investigated thoroughly,
the enzyme(s) acting to remove CoA from DHN-CoA has not been clearly identified yet.
Initially, CoA was thought to be cleaved non-catalytically following the cyclization
catalyzed by MenB (17). The observation that the product of MenB catalyzed reaction
was found to be DHN-CoA instead of DHN invalidated this mechanistic proposal (1). An
α/β-fold enzyme termed MenH, which can also act as a thioesterase, was identified
through inspection of the menaquinone biosynthetic operon of E. coli (10). In spite of the
fact that no direct evidence shows that MenH or its orthologs displays activity against
DHN-CoA, this protein was assumed to be the missing CoA thioesterase (7). In 2008,
Ming et al. demonstrated that MenH actually catalyzes the conversion of 2-succinyl-5enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate to (1R,6R)-2-succinyl-6-hydroxy2,4-cyclohexadiene-1-carboxylate, which is an earlier step in the menaquinone
biosynthetic pathway (18). In early 2009, Joshua et al. reported a hot-dog thioesterase,
Slr0204 from Synechocystis, which participates in the biosynthesis of phylloquinone, as
the enzyme responsible for the hydrolysis of DHN-CoA (19)
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In the study described below, we demonstrated that the C-terminal hotdog fold
domain of the Bacteroides fusion protein catalyzes the hydrolysis of DHN-CoA and thus
functions in the menaquinone biosynthesis pathway.

2.2 Experiments and Materials
2.2.1 Materials
All chemicals were obtained from Sigma-Aldrich. Primers, T4 DNA ligase, and
restriction enzymes were purchased from Invitrogen, Pfu, Pfu Turbo polymerases were
from Stratagene, the pET23a and pET-3A vector kits were from Novagen, the Geneclean
Spin and the Qiaprep Spin Miniprep kits were from Qiagen, Genomic DNA from
Bacteroides thetaiotaomicron VPI-5482 (ATCC-29148D) was from ATCC, and DEAE
Sepharose was from Amersham Biosciences. All aqueous solutions were prepared using
deionized water. Biosynthesis products were analyzed and separated by using a Shimadzu
LC-20AB HPLC system equipped with Beckman Coulter ultrasphere C18 analytical
column and Restek Ultra II C18 column.
1

H and

13

C spectra were recorded using a Bruker Avance 500 spectrometer. 1H

NMR data are reported as follows: chemical shifts (ppm), and multiplicities (s = singlet,
d = doublet, t = triplet, q = quartet, m = multiplet). 13C NMR chemical shifts are reported
in ppm relative to NH4HCO3 (160 ppm). Mass spectrometric data were obtained at the
University of the New Mexico mass spectrometry facility.

2.2.2 Preparation of the recombinant HAD-thioesterase fusion proteins PG1653 and
BF1314.
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The genes encoding the HAD-thioesterase fusion protein PG1653 (NCBI
accession NP905773, Swiss Pro accession: Q7MU91) and BF1314 (NCBI accession
YP098598, Swiss Pro accession: Q5LFS7) were amplified from Porphyromonas
gingivalis W83 and Bacteroides fragilis genomic DNAs by using PCR and then
subcloned into a pET-28a vector, which adds a His6 tag to the N-terminus of each
protein. The oligonucleotide primers were 5’-CAA ATT TTA CTG CAT ATG AAG
TAT AAA ATC-3’ (PG1653 forward), 5’-GGA AAA AAC GTC CTC GAG CCG CTG
TTT CAG GAT-3’ (PG1653 reverse), 5’-GAG CAT ATG AAG TAT AAC TGT TAG
TCC-3’ (BF1314 forward) and 5’-TTG AAG CTT CTA ACG TCA TCT TTT CTT-3’
(BF1314 reverse), which contain restriction the endo-nuclease cleavage sites Nde I and
Xho I. The integrities of the subcloned genes were demonstrated by using full length
DNA sequencing.
Gene expressions were performed by using E. coli BL21 (DE3) competent cells.
Following growth in 3 L of LB media containing 50 μg/mL of Kanamycin at 37 °C for 6
h with 220 rpm mixing, induction was initiated by the addition of 0.2 mM isopropyl-1thio-β-D-galactopyranoside (IPTG). After incubation for 12 h at 20 °C and 170 rpm
mixing, the cells were harvested by using centrifugation (6,500 rpm for 15 min at 4 °C),
resuspended in 300 mL of lysis buffer (50 mM HEPES, 300 mM NaCl, 10 mM
imidazole, pH 8.0) and lysed by 2 passages through a French Press cell (12,000 psi). The
cell lysate was centrifuged at 20,000 rpm for 60 min at 4 °C. The supernatant containing
the fusion proteins was eluted through a Ni+2 affinity column. The column was washed
with 200 mL of lysis buffer and 200 mL of wash buffer (50 mM HEPES, 300 mM NaCl,
20 mM imidazole, pH 8.0) before introduction of the fusion proteins and subsequently
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eluted with 100 mL of elution buffer (50 mM HEPES, 300 mM NaCl, 250 mM
imidazole, pH 8.0). The protein containing fractions were concentrated by using a 10 kDa
Macrosep centricon (Pall Filtron). Imidazole was removed by dialysis in 50 mM HEPES,
300 mM NaCl, pH 7.5. The purities of the proteins were determined by using SDS-PAGE
gel electrophoresis and their concentrations were determined by using the Bradford
method (absorbance at 280 nm, PG1653  = 21478 M-1cm-1 and BF1314  = 24579 M1

cm-1).

2.2.3 Preparation of recombinant O-succinylbenzoyl-coenzyme A ligase
The genes encoding the O-succinylbenzoyl-coenzyme A ligase (MenE) from E.
coli (K12), were amplified from genomic DNA by using PCR and cloned into the pET23a vector, which adds a His6 tag to the C-terminus of the protein for later purification.
The oligodeoxynucleotide primers used in gene amplification were 5’-GGA GCG GTT
CAT ATG ATC TTC TCT GAC-3’ (MenE forward), 5’-GAA GTG AAA CTC GAG
GGT TAA ATA TTG CTG ACG TTG CAC-3’ (MenE reverse), which contain the
restriction endonuclease cleavage sites NdeI and XhoI. Plasmid DNAs were purified
using a Qiaprep Spin Miniprep Kit. Gene sequencing was carried out at the Center for
Genetics in Medicine, University of New Mexico School of Medicine.
Gene expression was carried out in transformed E. coli BL21(DE3) cells.
Following growth in 3 L of LB media containing 50 μg/mL carbarnicillin at 37 °C for 12 h
with mixing at 220 rpm, induction was initiated by the addition of 1 mM isopropyl-1-thioβ-D-galactopyranoside. After incubation for 10 h at 20 °C and 170 rpm, the cells were
harvested by centrifugation (6500 rpm for 15 min at 4 °C), resuspended in 300 mL of lysis
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buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, 1 mM DTT, pH 8.0) and lysed
by 2 passages through a French Press cell (12,000 psi). The lysate was centrifuged at
20,000 rpm for 90 min at 4 °C, and the supernatant containing MenE was passed through a
Ni+1 affinity column for His6-tagged protein binding. The column was washed with 100 mL
of lysis buffer and 100 mL of wash buffer (50 mM NaH2PO4, 600 mM NaCl, 50 mM
imidazole, 1 mM DTT, pH 8.0) before MenE was subsequently eluted using 100 mL of
elution buffer (50 mM NaH2PO4, 600 mM NaCl, 250 mM imidazole, 1 mM DTT, pH 8.0).
The eluant was concentrated by using a 10 kDa Macrosep centricon (Pall Filtron) device.
Imidazole was removed by chromatography on a S-200 resin using 50 mM NaH2PO4, 600
mM NaCl, pH 7.5 as the elution buffer. The purity of the protein was determined by using
SDS-PAGE and its concentration was determined by using the Bradford method
(absorbance at 280 nm, = 104,770 M-1 cm-1).

2.2.4 Preparation of recombinant 1,4-dihydroxynaphthoyl-CoA synthase
The genes encoding 1,4-dihydroxynaphthoyl-CoA synthase (MenB) from E. coli
(K12), were amplified from genomic DNA by using PCR and cloned into a pET-14b
vector, which adds a His6 tag to the N-terminus of the protein for later purification. The
oligodeoxynucleotide primers used in gene amplification were 5’-CAC CAT ATG ATT
TAT CCT GAT GAA GCA-3’ (MenB forward), 5’-ATA CCT GCG CGC CTC GAG
TTA CGG ATT CCG-3’ (MenB reverse), which contain the restriction endonuclease
cleavage sites NdeI and XhoI. Plasmid DNAs were purified using a Qiaprep Spin Miniprep
Kit. Gene sequencing was carried out at the Center for Genetics in Medicine, University of
New Mexico School of Medicine.
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Gene expression was carried-out in transformed E. coli BL21(DE3) cells.
Following growth in 3 L of LB media containing 50 μg/mL carbarnicillin at 37 °C for 12 h
with mixing at 220 rpm, induction was initiated with the addition of 1 mM isopropyl-1thio-β-D-galactopyranoside. After incubation for 10 h at 20 °C 170 rpm, the cells were
harvested by centrifugation (6500 rpm for 15 min at 4 °C), resuspended in 300 mL of lysis
buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, 1 mM DTT, pH 8.0) and lysed
by 2 passages through a French Press cell (12,000 psi). The cell lysate was centrifuged at
20,000 rpm for 90 min at 4 °C, and the supernatant containing MenB was passed through a
Ni+1 affinity column. The column was washed with 100 mL of lysis buffer and 100 mL of
wash buffer (50 mM NaH2PO4, 600 mM NaCl, 50 mM imidazole, 1 mM DTT, pH 8.0)
before MenB was subsequently eluted using 100 mL of elution buffer (50 mM NaH2PO4,
600 mM NaCl, 250 mM imidazole, 1 mM DTT, pH 8.0). The protein was concentrated by
using a 10 kDa Macrosep centricon (Pall Filtron) device. Imidazole was removed by
chromatography on S-200 resin using 50 mM NaH2PO4, 600 mM NaCl, pH 7.5 as the
elution buffer. The purity of the proteing was determined by using SDS-PAGE and its
concentration was determined by using the Bradford method (absorption at 280 nm (MenB
extinction coefficient = 41,370 M-1 cm-1).

2.2.5 Preparation of O-succinoylbenzoate 23
The route used for preparation of this substance is outlined in Scheme 2.2. A
solution of 2-formylbenzoic acid 20 (27 g, 0.18 mol), iodomethane (49 g, 0.34 mol), and
K2CO3 (14 g, 0.10 mol) in 200 mL of DMF was stirred at reflux for 1 h. The mixture was
poured into 150 mL of water and then extracted with CH2Cl2. The organic layer was
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washed successively with water, aqueous HCl, aqueous NaHCO3, and brine, dried over
anhydrous Na2SO4, and then concentrated in vacuo to give a colorless oil, which slowly
crystallized to give pure methyl 2-formylbenzoate 18 (30.2 g, 100%). 1H NMR (500
MHz, d4-CDCl3): δ 10.57 (s, 1H), 7.92(t, 2H), 7.60 (m, 2H), 3.93 (s, 3H). This spectrum
matched that previously reported for 18 (20).

Scheme 2.2 Organic synthesis of O-succinoylbenzoate

A solution of 18 (2 g, 0.011 mol) in dry dichloromethane (100 mL) containing
suspended anhydrous zinc chloride (8.16 g, 0.060 mol) was stirred at 0 °C for 30 min. To
this solution was added 1-ethoxy-1-trimethylsiloxycyclopropane 19 (4.2 g, 0.024 mol)
dropwise at 0 °C. The mixture was warmed to room temperature and stirred over night.
After addition of dilute HCl, the organic layer was separated and concentrated in vacuo,
giving a residue that was subjected to flash chromatography on silica gel using 5:1
hexane:acetone as the eluant to yield the lactone 20. 1H NMR (500 MHz, d4-CDCl3): δ
7.81 (d, 1H), 7.63 (s, 1H), 7.48(s, 1H), 7.42 (d, 1H), 5.50 (t, 1H), 4.05 (t, 2H), 2.39 (m,
3H), 1.94 (m, 1H), 1.18 (s, 3H).

13

C NMR (125 MHz, d4- CDCl3): δ172.31, 169.98,
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149.06, 133.99, 129.16, 125.53, 121.76, 79.85, 60.47, 29.66, 29.24, 13.97. These spectra
matched those previously reported for 20 (20).
A solution of 20 (1 g, 4.27 mmol) in glacial acetic acid (20 mL) containing
chromium trioxide (2 g, 0.020 mol) was stirred at room temperature for 12 h. The mixture
was diluted with water and extracted with ethyl acetate. Concentration of the extract in
vacuo gave a residue that was subjected to silica gel chromatography using 2:1
hexane:acetone as the eluant to yield ethyl o-succinoylbenzoate 21. 1H NMR (500 MHz,
d4-CDCl3): δ 7.78 (s, 1H), 7.66 (d, 1H), 7.53 (t, 2H), 4.10 (d, 2H), 2.70 (d, 1H), 2.52 (s,
1H), 2.43 (s, 1H), 2.24 (s, 1H), 1.22 (s, 3H). 13C NMR (125 MHz, d4- CDCl3): δ 204.48,
174.12, 168.32, 148.91, 134.66, 130.56, 126.36, 125.40, 122.23, 106.49, 61.23, 33.90,
28.98, 14.00. These spectra matched those previously reported for 21 (20).
A solution of 21 (1 g, 4.0 mmol) in 50 mL methanol containing 3 mL of 50%
(w/v) aqueous NaOH was stirred at room temperature overnight. Concentration in vacuo
gave compound O-succinylbenzoate 23. 1H NMR (500 MHz, d4-H2O): δ 7.67 (d, 1H),
7.61 (s, 2H), 7.57 (q, 1H), 3.23 (t, 2H), 2.57 (t, 2H),

13

C NMR (125 MHz, d4- H2O): δ

201.61, 174.64, 169.56, 130.74, 124.31, 122.32, 120.59, 120.22, 31.06, 27.18, 24.88. MS:
m/z calculated for C11H18O3 [M+H}+, 221.03; found 221.04.

2.2.6 Enzymatic synthesis of 1,4-dihydroxynaphthoyl-CoA
1,4-Dihydroxynaphthoyl-CoA was biosynthesized by using the menaquinone
pathway proteins MenE and MenB. To a solution of o-succinylbenzoate (26.1 mg, 100
mmol), coenzyme A (44 mg, 56 mmol), and ATP (30.9 mg, 56 mmol) in 470 L of
reaction buffer (20 mM Tris, 1 mM MgCl2, 50 mM NaHCO3, pH 7.8) was added 10 L

43

MenB (2 mM) and 20 L MenE (300 uM). The resulting mixture was incubated at 37 °C
for 30 min and filtered by using a Microcon ultracel centrifuge filter (pore size 30 kDa).
The filtrate was subjected to Shimadzu LC-20 HPLC using a Beckman Coulter
ultrasphere C18 analytical column and a linear gradient from (100% solvent A) to (60%
solvent A plus 40% solvent B) over 45 min at a flow rate of 1 mL/min. Solvent A was a
50 mM ammonium acetate (pH 5.9) and solvent B methanol. Fractions containing DHNCoA were combined and lyophilized to give solid 1,4-dihydroxynaphthoyl-CoA. 1H
NMR (500 MHz, D2O): δ 8.69 (s, 1H), 8.63 (s, 1H), 8.47 (s, 1H), 8.41 (s, 1H), 7.91 (s,
1H), 7.78 (s, 1H), 6.24 (d, 1H), 6.14 (d, 1H), 4.66 (s, 1H), 4.32 (s, 2H), 4.06 (s, 1H), 3.91
(s, 1H), 3.74 (s, 1H), 3.68 (s, 2H), 3.51 (m, 4H), 2.79 (s, 1H), 2.50 (s, 1H), 2.33 (s, 1H),
0.98 (s, 3H), 0.87 (s, 3H). Mass spectrometric analysis: observed 954.13 Da; calculated
(M+H for C32H42N7O19P3S) 954.15.

2.2.7 Preparation of the truncated HAD domain of PG1653
The HAD domain of the fusion protein PG1653 was prepared by using site-directed
mutagenesis. The codon for Val271 was mutated to a stop codon TAA through quick
change techniques. Oligonucleotide primers 5’- CGA ATA TGA AGC CTA ACC TTT
CTC CGT AGA -3’ (forward), and 5’- TCT ACG GAG AAA GGT TAG GCT TCA TAT
TCG -3’ (reverse) were used in the reaction. Plasmid DNA was purified using a Qiaprep
Spin Miniprep Kit. Gene sequencing was carried out at the Center for Genetics in
Medicine, University of New Mexico School of Medicine.
Gene expression was carried out in transformed BL21 (DE3) cells. Following
growth in 3 L of LB media containing 50 μg/mL Kanamycin at 37 °C for 6 h with mixing
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at 220 rpm, induction was initiated by the addition of 0.2 mM isopropyl-1-thio-β-Dgalactopyranoside. After incubation for 12 h at 20 °C 170 rpm, the cells were harvested
by centrifugation (6500 rpm for 15 min at 4 °C), resuspended in 300 mL of lysis buffer
(50 mM HEPES, 300 mM NaCl, 10 mM imidazole, pH 8.0) and lysed by 2 passages
through a French Press cell (12,000 psi). The lysate was centrifuged at 20,000 rpm for 60
min at 4 °C and the supernatant containing PG-HAD was passed through a Ni+2 affinity
column. The column was washed with 200 mL of lysis buffer and 200 mL of wash buffer
(50 mM HEPES, 300 mM NaCl, 20 mM imidazole, pH 8.0) before elution with 100 mL
of a mixture of 50 mM HEPES, 300 mM NaCl, and 250 mM imidazole (pH 8.0). The
protein solution was concentrated by using a 10 kDa Macrosep centricon (Pall Filtron)
device. Imidazole was removed by dialysis in 50 mM HEPES, 300 mM NaCl (pH 7.5).
The protein purity was verified by using SDS-PAGE and the protein concentration was
determined by using the Bradford method and by measuring the absorption at 280 nm
(=16,765 M-1 cm-1).

2.2.8 Preparation of the truncated thioesterase domain of PG1653
The genes encoding the thioesterase domain of fusion protein PG1653 gene (NCBI
accession NP905773, Swiss Pro accession: Q7MU91) was amplified from Porphyromonas
gingivalis W83 and Pfu DNA polymerase and Pfu DNA polymerase. The PCR product was
cloned into the PET-28b vector, which was used to transform competent E. coli. BL21
(DE3) cells. Oligonucleotide primers 5’-TAT GAA GCC CAT ATG TTC TCC GTA
GAA-3’ (forward) and 5’-ATG GGA AAA AAG CTT TTA CCG CTG TTC AGG-
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3’(reverse), containing the restriction endonuclease cleavage sites NdeI and HindIII, were
used in the PCR reactions. The Pro272 codon was mutated to a start codon.
Gene expression was performed using transformed BL21 (DE3) cells. Following
growth in 3 L of LB media containing 50 μg/mL Kanamycin at 37 °C for 6 h with mixing
at 220 rpm, induction was initiated by the addition of 0.2 mM isopropyl-1-thio-β-Dgalactopyranoside. After incubation for 12 h at 20 °C 170 rpm, the cells were harvested
by centrifugation (6500 rpm for 15 min at 4 °C), resuspended in 300 mL of lysis buffer
(50 mM HEPES, 300 mM NaCl, 10 mM imidazole, pH 8.0) and lysed by 2 passages
through a French Press cell (12,000 psi). The lysate was centrifuged at 20,000 rpm for 60
min at 4 °C, and the supernatant was passed through a Ni+2 affinity column. The column
was washed with 200 mL of lysis buffer and 200 mL of wash buffer (50 mM HEPES,
300 mM NaCl, 20 mM imidazole, pH 8.0) before using 100 mL of elution buffer (50 mM
HEPES, 300 mM NaCl, 250 mM imidazole, pH 8.0). SDS-PAGE gel analysis shows that
all the PG-TE was present in the pellet.

2.2.9 Mutagenesis of the PG1653 fusion protein and the truncated HAD domain
The F11D mutants were prepared by using quick change mutagenesis.
Oligonucleotide primers 5’- TA GTC ATA GAT GTA GAC AAC ACC CTG CTC A -3’
(forward), 5’- T GAG CAG GGT GTT GTC TAC ATC TAT GAC TA -3’ (reverse). The
gene sequences were confirmed at the Center for Genetics in Medicine, University of
New Mexico School of Medicine.
Gene expression was carried out in BL21 (DE3) cells. Following growth in 3 L of
LB media containing 50 μg/mL Kanamycin at 37 °C for 6 h with mixing at 220 rpm,
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addition

of

0.2

mM

isopropyl-1-thio-β-D-

galactopyranoside. After incubation for 12 h at 20 °C 170 rpm, the cells were harvested
by centrifugation (6500 rpm for 15 min at 4 °C), resuspended in 300 mL of lysis buffer
(50 mM HEPES, 300 mM NaCl, 10 mM imidazole, pH 8.0) and lysed by 2 passages
through a French Press cell (12,000 psi). The lysate was centrifuged at 20,000 rpm for 60
min at 4 °C, and the supernatant was passed through a Ni+2 affinity column. The column
was washed with 200 mL of lysis buffer and 200 mL of wash buffer (50 mM HEPES,
300 mM NaCl, 20 mM imidazole, pH 8.0) before using 100 mL of elution buffer (50 mM
HEPES, 300 mM NaCl, 250 mM imidazole, pH 8.0). The proteins solution were
concentrated by using 10 kDa Macrosep centricon (Pall Filtron) devices. Imidazole was
removed by dialysis in 50 mM HEPES, 300 mM NaCl (pH 7.5). The proteins’ purities
were verified by using SDS-PAGE and their concentrations were determined by using the
Bradford method and by measuring the absorption at 280 nm (=16500 M-1 cm-1 for
HAD domain mutant and 25500 M-1 cm-1 for fusion protein mutant)

2.2.10. Preparation of the truncated HAD domain of BF1314
The HAD domain of the fusion protein PG1653 was prepared by using site-directed
mutagenesis. The Arg273 codon was mutated to a stop codon TAA using quick change
techniques. Oligonucleotide primers 5’- CTT TCT GAG ATT TAA CCG GCA GAG
ATTCCT-3’ (forward) and 5’- AGG AAT CTC TGC CGG TTA AAT CTC AGA AAG-3’
(reverse). Plasmid DNA was purified using a Qiaprep Spin Miniprep Kit. Gene sequencing
was carried out at Mclab.
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Gene expression was performed using BL21 (DE3) competent cells. Following
growth in 3 L of LB media containing 50 μg/mL Kanamycin at 37 °C for 6 h with mixing
at 220 rpm, induction was initiated by the addition of 0.2 mM isopropyl-1-thio-β-Dgalactopyranoside. After incubation for 12 h at 20 °C 170 rpm, the cells were harvested
by centrifugation (6500 rpm for 15 min at 4 °C), resuspended in 300 mL of lysis buffer
(50 mM HEPES, 300 mM NaCl, 10 mM imidazole, pH 8.0) and lysed by 2 passages
through a French Press cell (12,000 psi). The lysate was centrifuged at 20,000 rpm for 60
min at 4 °C and the supernatant was passed through a Ni+2 affinity column. The column
was washed with 200 mL of lysis buffer and 200 mL of wash buffer (50 mM HEPES,
300 mM NaCl, 20 mM imidazole, pH 8.0) before elution with 100 mL of a mixture of 50
mM HEPES, 300 mM NaCl, and 250 mM imidazole (pH 8.0). The protein solution was
concentrated by using a 10 kDa Macrosep centricon (Pall Filtron) device. Imidazole was
removed by dialysis in 50 mM HEPES, 300 mM NaCl (pH 7.5). The protein purity was
verified by using SDS-PAGE and its concentration was determined by using the Bradford
method and by measuring the absorption at 280 nm (=19335 M-1 cm-1).

2.2.11. Preparation of truncated thioesterase domain of BF1314
The gene encoding the HAD domain of the fusion protein BF1314 gene (NCBI
accession YP098598, Swiss Pro accession: Q5LFS7) from Bacteroides fragilis was
amplified by using PCR with genomic DNA from Bacteroides fragilis and Pfu DNA
polymerase. The PCR product was cloned into the PET-28b vector, which was used to
transform using E. coli. BL21 (DE3). Oligonucleotide primers 5’- CTT TCT GAG ATT
CAT ATG GCA GAG ATT CCT-3’ (forward) and 5’-ATG GGA AAA AAG CTT TTA
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CCG CTG TTC AGG-3’(reverse), containing the restriction endonuclease cleavage sites
NdeI and HindIII, were used in the PCR reactions. The Pro274 codon was mutated to a
start codon. Gene sequencing was carried out at Mclab.
Gene expression was performed using BL21 (DE3) competent cells. Following
growth in 3 L of LB media containing 50 μg/mL Kanamycin at 37 °C for 6 h with mixing
at 220 rpm, induction was initiated by the addition of 0.2 mM isopropyl-1-thio-β-Dgalactopyranoside. After incubation for 12 h at 20 °C 170 rpm, the cells were harvested
by centrifugation (6500 rpm for 15 min at 4 °C), resuspended in 300 mL of lysis buffer
(50 mM HEPES, 300 mM NaCl, 10 mM imidazole, pH 8.0) and lysed by 2 passages
through a French Press cell (12,000 psi). The lysate was centrifuged at 20,000 rpm for 60
min at 4 °C, and the supernatant was passed through a Ni+2 affinity column. The column
was washed with 200 mL of lysis buffer and 200 mL of wash buffer (50 mM HEPES,
300 mM NaCl, 20 mM imidazole, pH 8.0) before using 100 mL of elution buffer (50 mM
HEPES, 300 mM NaCl, 250 mM imidazole, pH 8.0). The protein solution was
concentrated by using a 10 kDa Macrosep centricon (Pall Filtron) device. Imidazole was
removed by dialysis in 50 mM HEPES, 300 mM NaCl (pH 7.5). The protein purity was
verified by using SDS-PAGE and its concentration was determined by using the Bradford
method and by measuring the absorption at 280 nm (=8480 M-1 cm-1).

2.2.12. Steady-state kinetic measurements
Thioesterase Activity Assay. For most substrates tested, thioesterase activities
were determined by measuring the rate of formation of CoA using the 5,5’-dithio-bis-(2nitrobenzoic acid) (DTNB) coupling assay. Reaction solutions (1 mL) initially containing
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specified concentrations of the substrates, 1 mM DTNB, 0.15 M KCl and 50 mM
K+HEPES (pH 7.5), were monitored at 412 nm.
Phosphatase Activity Assay.The phosphatase activities of the HAD domains were
determined by measuring the production of phosphate using an EnzChek phosphate assay
kit from Invitrogen. Reaction solutions (1 mL) initially containing specified concentrations
of substrate, purine nucleoside phosphorylase, MESG, 20 mM Tris-HCl, 2 mM MgCl2, and
2 mM sodium azide (pH 7.5), were monitored at 360 nm.
MenE Activity Assay. The activities of substrates toward MenE were determined by
using a coupled assay that detects the formation of AMP through the sequential reactions
catalyzed by adenylate kinase, pyruvate kinase, and lactate dehydrogenase. Reaction
solutions (1 mL) which initially contained specified concentrations of substrates, 15 mM
MgCl2, 200 μM NADH, 3 mM PEP, 5 mM KCl, 11 units adenylate kinase, 9 units
pyruvate kinase and 9 units lactate dehydrogenase in 50 mM K+HEPES (pH 7.5, 25 °C)
were monitored 340 nm.
MenB Activity Assay. Reaction solutions which initially contained 50 mM
K+HEPES (pH 7.5), 200 µM ATP, 200 µM CoA, 1 mM MgCl2, 1 µM MenE and specified
concentrations of substrate were incubated for 5 min at 25 °C to covert the OSB to OSBCoA. Subsequently MenB was added to the reaction mixture. The increase in absorbance at
392 nm resulting from the formation of DHN-CoA was monitored.
Steady-state Kinetic Constant Determination.
The initial velocities of the reactions were measured as a function of the concentration of
the substrates, which varied in the range of 0.5 to 10-fold KM. The data were fitted using an
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enzyme kinetic module in sigmaplot to define Vmax and KM. The kcat was calculated from
the ratio of Vmax and enzyme concentration.
V = Vmax[S]/([S] + KM)
where V is the initial velocity, Vmax the maximum velocity, [S] the substrate concentration,
KM the Michaelis constant.

2.2.13 Protein native mass determination by size exclusion chromatography
Chromatographies were carried out using an ÄKTA P-920 FPLC system and
Hiprep 16/60 Sephacryl S-200 HR column (GE Healthcare). The size exclusion column
was equilibrated with 50 mM HEPES (pH 7.5), 500 mM NaCl, and 1 mM DTT. The
column was calibrated using the gel-filtration low molecular weight and high molecular
weight gel filtration calibration kit from Amersham Biosciences. Purified protein (2 mL,
ca. 200 mM) was applied to the column.

2.3 Results and Discussion
2.3.1 Biosynthesis of 1,4 dihydroxy Naphthoyl-CoA

Scheme 2.3 Biosynthesis of 1,4 dihydroxy naphthoyl-CoA

Synthetic O-succinylbenzoate (OSB) was converted to the corresponding CoA
thioester using recombinant E. coli menE as the catalyst and (3 mM) ATP and (1 mM)
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CoA as co-substrates (at pH 7.5 and 25 oC kcat = 11 ± 0.2 s-1, O-succinylbenzoate Km = 8
± 0.5 µM and O-succinylbenzoate kcat/Km = 1.4 x 106 M-1 s-1). At a fixed OSB
concentration of 50 µM and CoA concentration of 300 µM the kcat = 9 ± 0.2 s-1 and ATP
Km = 380 ± 30 µM. At a fixed OSB concentration of 50 µM and ATP concentration of
400 µM kcat = 10 ± 0.2 s-1 and Km = 227 ± 16 µM (see Lineweaver-Burk plots in Figure.
2.3). The OSB-CoA generated in situ was converted to the DHN-CoA using recombinant
MenB as catalyst (Scheme 2.3) (kcat = 5 ± 0.2 s-1 and Km = 35 ± 3 µM).
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Figure 2.3 Lineweaver-Burk plots of the initial velocity data derived from (a)
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MenB catalyzed reaction of OSB-CoA. (b) MenE catalyzed reaction of OSB
(concentration varied), ATP (3mM) and CoA (1mM). (c) MenE catalyzed reaction of
OSB (50 M), ATP (400 µM) and CoA (concentrated varied). (d) MenE catalyzed
reaction of OSB (50 M), ATP (concentration varied) and CoA (300 µM).

The DNH-CoA was separated from the crude reaction mixture by HPLC (see Figure 2.4).
A typical preparative reaction provided DNH-CoA in 60% yield.

A
AMP

DHN-CoA

B
ATP

OSB

CoA

Figure 2.4. HPLC traces of MenB and MenE mixtures from catalyzed reactions of OSB
to form DHN-CoA synthesis monitored at 292 nm. (Trace B is the mixture of 2.5 mM
OSB, ATP and CoA without enzymes; Trace B is the MenE and MenB assisted
biosynthesis of DHN-CoA. Reactions were carried out at 37 °C with 50 mM K+HEPES,
2.5 mM ATP, 2.5 mM CoA, 1 mM MgCl2, pH 7.5 containing 0.1 mM MenE and 0.2 mM
MenB and 10 mM of the MenB activator sodium bicarbonate. Retention times: DNHCoA 37.9 min, OSB 5.8 min, ATP 7.7 min and CoA 19.1 min.
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The stability of DNH-CoA in 25 °C in 50 mM HEPES pH 7.5 buffer was
examined. The HPLC trace of the reaction solution measured at 8 and 20 h of incubation
(Figure 2.5) indicates a half life ~ 8 h.

DHN
20 hours

8 hours

DHN-CoA

Figure 2.5. HPLC trace of the DHN-CoA decomposition reaction in 50 mM HEPES
buffer (pH=7.5) at 25 °C.

2.3.2 Function of the thioesterase domain of the fusion protein determined by
steady-state kinetic substrate screening
The steady-state kinetic constants (Table 2.1) of possible substrates for the P.
gingivalis and B. fragilis HAD-thioesterase fusion protein (PG1653 and BF1314) were
determined at pH 7.5 and 25 °C by carrying out initial velocity measurements, in which
the enzyme is held at a fixed concentration while the concentration of the thioester
substrate was varied in the range of 0.5-10 fold Km.
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Figure 2.6 Lineweaver-Burk plots of a) PG1653 and b) BF1314 catalyzed DHN-CoA
hydrolysis reactions in 50 mM K+HEPES (pH 7.5, 25 oC)

Table 2.1 Steady-state kinetic constants (kcat, Km and kcat/Km) for substrates for
hydrolysis reactions catalyzed by the HAD-thioesterase fusion protein PG1653 and
BF1314 (50 mM K+HEPES, pH 7.5, 25 oC) using the DTNB assay unless otherwise
noted.
Substrate

kcat (s-1)

Km (μM)

kcat/Km
(M-1. s-1)

butyl-CoA

< 1 x 10-4

--------

--------

Benzoyl-CoA

(3.0 ± 0.1) x 10-2

(5.8 ± 0.5) x101

5.5x102

4-Hydroxybenzoyl-CoA

4.6 ± 0.1

(8.0 ± 0.5) x 102

5.8x103

4-Chlorobenzoyl-CoA

2.8 ± 0.1

(1.2 ± 0.1) x 102

2.3x105

4-Iodobenzoyl-CoA

5.4 ± 0.1

(6.5 ± 0.5) x 101

8.3x105

4-Methoxybenzoyl-CoA

(2.5 ± 0.2) x 10-1

(2.2 ± 0.1) x 102

1.1x103

Naphthoyl-CoA

6.9 ± 0.2

(1.7 ± 0.2) x 102

4x105

1,4-Dihydroxynaphthoyl-CoA
(PG1653)
1,4-Dihydroxynaphthoyl-CoA
(BF1314)
3,4-Dihydroxy
phenylacetyl-CoA

(1.0 ± 0.1) x 101

4.0 ± 0.3

2.5x106

(1.2 ± 0.1) x 101

7.0 ± 0.5

1.7x106

(4.0 ±0.1) x 10-2

(2.2 ± 0.2) x 102

1.6x102
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(1.7 ± 0.1) x 10-1

(1.4 ± 0.1) x 102

1.2x103

4-Hydroxyphenylacetyl-CoA

(1.5 ± 0.1) x 10-1

(3.9 ± 0.3) x 101

3.8x103

3-Hydroxyphenylacetyl-CoA

(3.1 ± 0.2) x 10-1

(1.7 ± 0.1) x 102

1.8x103

4-Hydroxyphenylacetyl-CoA
a

a

The direct assay was used

The UV spectrum of PG1653 and BF1314 showed a 280 nm max with no
additional absorbance at 260 nm. Likewise neither enzyme reacted with DTNB. Thus,
CoA did not co-purify with either of the two proteins. PG1653 and BF1314 had kcat and
Km values of 10.0  0.3 s-1, 4.0  0.3 µM, and 12.0  0.3 s-1, 7.0  0.5 µM, respectively,
for reaction of DHN-CoA. The large respective kcat /Km values of 2.5 x 106 and 1.7 x 106
M-1 s-1 (Fig. 2.6a, 2.6b and Table 2.1) indicate that DNH-CoA is the physiological
substrate. The substrate specificity profile determined for PG1653 supports this
conclusion. Namely, catalysis is limited to aromatic CoA thioesters and among these the
napthyl > benzoyl > phenyacetyl. Even removal of the two hydroxyl groups from the
DNH-CoA napthyl ring significantly reduced the kcat/Km value (Table 2.1).
The BF1314 gene was genetically engineered to express the thioesterase domain
as a standalone protein (residues 274-410) (BF-TE). This protein was purified and tested
for catalytic activity towards the DHN-CoA substrate. No activity was observed.

2.3.3 Function of HAD domain of fusion protein determined by steady-state kinetic
substrate screen
The function of the HAD domain of the HAD-thioesterase fusion proteins was
investigated by screening catalytic activity towards the hydrolysis of a variety of
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phosphate esters. BF1314 displayed a very low level of activity towards substrates that
are most susceptible to spontaneous hydrolysis, namely carbamoyl phosphate,
imidodiphosphate and acetyl phosphate (respective kcat/Km values of 54 M-1 s-1, 37 M-1 s-1
and 16 M-1 s-1). The organophosphate metabolites that were found to have no detectable
substrate activity when tested at a concentration of 1 mM in solutions containing 10 M
BF1314, 1 mM MgCl2 and 20 mM Tris-HCl (pH 7.5 and 25 oC) include 100 µM sodium
azide.
The BF1314 gene was genetically engineered to express the HAD domain as a
standalone protein (residues 1 to 273). This protein (BF-HAD) displayed higher activities
as compared to the fusion protein. For example, the kcat/Km value of 1.9 x 102 M-1 s-1 was
observed for glycerol-phosphate at pH 7.5 (Table 2.2). Replacing the Mg2+ cofactor with
Mn2+ did not significantly change the activity, whereas replacing it with Co2+ precluded
the activity. The pH rate profile (Figure 2.7b) showed that the BF-HAD is maximally
active at pH 5.5 (kcat/Km = 1.2 x 103 M-1 s-1; Figure 2.7a and Table 2.2). Thus, the HAD
domain has a low level of activity towards a phosphate ester metabolite which is
somehow suppressed by the presence of the thioesterase domain.

Table 2.2 Steady-state kinetic data of HAD-thioesterase fusion protein BF1314 and BFHAD (20 mM Tris, 1 mM metal ions, pH 7.5, 25 oC).
BF1314
Substrate
paraNitrophenyl
phosphate
Carbamoyl
phosphate

BF-HAD

kcat
-1
(s )

Km
(µM)

kcat /Km
-1 -1
(M s )

kcat
-1
(s )

Km
(µM)

kcat /Km
-1 -1
(M s )

< 1 x 10-4

--------

--------

< 1 x 10-4

--------

--------

(2.2 ± 0.1) x 10-2

(4.4 ± 0.3) x 102

5.4 x 101

(4.1 ± 0.3) x 10-2

(9.7 ± 0.8) x 102

4.2 x 101
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Imidodiphosphate
Acetylphosphate
Glycerolphosphate
Glycerolphosphate

(2.1 ± 0.1) x 10-1

(5.7 ± 0.5) x 103

3.7 x 101

(3.8 ± 0.2) x10-1

(7.4 ± 0.5) x 103

5.1 x 101

(8.0 ± 0.2) x 10-3

(5.1 ± 0.4) x 102

1.6 x 101

(2.0 ± 0.1) x 10-2

(8.7 ± 0.6) x 102

2.3 x 101

< 1 x 10-4

--------

--------

(1.1 ± 0.1) x 10-2

(6.3 ± 0.2) x 101

1.7 x 102

(1.0 ± 0.1) x 10-1

(8.7 ± 0.7) x 101

1.1 x 103

a
a

Measured at pH 5.5.
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Figure 2.7 (a) Lineweaver-Burk plots of the BF-HAD catalyzed glycerol-phosphate
hydrolysis reaction in 20 mM MES (pH 5.5, 25 oC), kcat/Km = 1.1 x 103 M-1 s-1; (b) pH
profile of the BF-HAD catalyzed glycerol-phosphate hydrolysis reaction.

Except for the listed substrate in table 2.2, several other organophosphate esters
are also tested, and both the fusion protein BF1314 the truncated HAD domain of
BF1314 are inactive towards these substrates. These substrates are: pyrophosphate,
erythrose 4-phosphate, fructose 1-phosphate, glucose 6-phosphate, glucose 1-phosphate,
ATP, AMP, ADP, UMP, farnesyl monophosphate, farnesyl-pyrophosphate, fructose 1,6bisphosphate, thiamine phosphate, threonine phosphate, serine phosphate, ribose 5phosphate, arabinose 5-phosphate, 2-keto, 3-deoxy, 6-phosphogluconate, Glyceraldehye
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3-phosphate, 6-phosphogluconic acid, 3-phospho

glycerate,

2-phosphoglycolate,

phosphoenolpyruvate.
Whereas the BF1314 active site contains a full set of stringently conserved
catalytic residues, the PG1653 does not. Specifically, the key Asp acid/base is replaced
by a Phe residue. Neither the wild-type enzyme of the F11D mutant displaced activity
against the panel of organophosphate substrates tested with the BF1314.

2.3.4 Native molecular weight of HAD-thioesterase fusion protein BF1314 and
truncated BF-HAD and BF-TE
To better understand the function of the purpose of the HAD domain in the
BF1314 fusion protein, the quaternary structures of holo enzyme and the two genetically
engineered single domain proteins (BF-HAD and BF-TE) were determined by size
exclusion chromatography (SEC). The calculated masses of the monomeric proteins (Mw,
calc)

and the observed (Mw, obs) masses of the native proteins in solution are listed in Table

2.3.
The holo BF1314 (residues 1-410) exclusively formed tetramers in solution
(Figure 2.8a), and tetramerization was also observed for the purified BF-HAD (residues
1-273; Figure 2.8b). The BF-TE (residues 274-410; Figure 2.8c), on the other hand is a
monomer. Notably, the minimal catalytic unit of a hotdog-fold thioesterase is a dimer
because the active site is located at the subunit-subunit interface. Bacterial hotdog-fold
thioesterases are dimer of dimer or trimer of dimer. HADs that possess cap domains are
monomers or dimers. The closest homolog to the BF1314 HAD domain is the type C2B
capped HAD phosphatase BT3352, which is described in Chapter 3. BT3352 is a
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monomer. HADs dimerize either using the cap domain or the catalytic domain. To form a
tetramer both the cap and catalytic domain would have participate. A priori, this would
preclude normal cap function. This might explain why the HAD domain has little
catalytic activity despite having the requisite catalytic residues (Table 2.2).
If the HAD domain functions to drive the dimerization of the thioesterase domain
then the removal of the HAD domain would explain why the thioesterase exists as a
monomer and as the monomer has an incomplete active site why the engineered
thioesterase domain is catalytically inactive (Table 2.4). The ability of the HAD domain
to drive dimerization of the thioesterase domain requires that the two domains are
tethered. Specifically, the size exculsion chromatography of a mixture of BF-HAD and
BF-TE separated the two proteins which indicates that the HAD and thioesterase domains
do not associate with one another.

(a)

192.9 kDa
(4.1 x 47.1 kDa)

BF1314
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(b)

130.2 kDa (4.3 x 30.0 kDa)

BF-HAD

(c)

15.2 kDa
(0.9 x 17.4 kDa)

BF-TE

61

114.0 kDa

(d)

13.4 kDa

BF-HAD + BF-TE

40
30
25
15

(e)

kDa

Figure 2.8 Size exclusion chromatography of (a) holo BF1314 (residues 1-410);
(b) BF-HAD; (c) BF1314 BF-TE, residues 274-410); (d) mixture of BF-HAD and BFTE; (e) 16% SDS-PAGE and Coomassie staining of (d).

Table 2.3. Molecular Masses holo BF1314, BF-HAD and BF-TE determined by
size exculsion chromatography.
Enzymes

Monomer

Sec

Oligomer

Mw, calc (kDa)

Mw, obs (kDa)

x-merobs

BF1314

47.1

192.9

4.1

Tetramer

BF-HAD

30.0

130.2

4.3

Tetramer

BF-TE

17.4

15.2

0.9

Monomer
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2.3.5 Effects between N-terminal HAD domain and C-terminal thioesterase domain
on the kinetic activities of fusion protein and truncated proteins
To further investigate the interaction between the truncated N-terminal HAD
domain and the C-terminal thioesterase domain, steady-state kinetic analysis was carried
out BF-HAD phosphates activity in the presence and absence of BF-TE, and on the BFTE thioesterase activity in the presence and absence of BF-HAD. Kinetic constants were
determined using equimolar amounts of the two single domain constructs. The kcat/Km
values reported in Tables 2.4 and 2.5 show that the presence of domain partner had
essentially no effect on the phosphatase or thioesterase activities. This indicates that the
two domains do not bind to one another, which is in agreement with the results from the
size exclusion chromatography.

Table 2.4 Steady state kinetic values measured for the HAD-thioesterase fusion protein
BF1314, BF-TE and a 1:1 mixture of BF-HAD and BF-TE for catalysis of 1,4-DHN-CoA
thioester hydrolysis (50 mM K+ HEPES, pH 7.5, 25 oC).

7.0 ± 0.5

kcat /Km
-1 -1
(M s )
1.7 x 106

< 1 x 10

-4

--------

--------

< 1 x 10

-4

--------

--------

kcat
-1
(s )
(1.2 ± 0.1) x 101

Enzymes
BF1314
BF-TE
BF-TE + BF-HAD

Km
(µM)

Table 2.5 Steady state kinetic values measured for BF-HAD and a 1:1 mixture of BFHAD and BF-TE phosphatase activity (50 mM K+ HEPES, pH 7.5, 25 oC).
Substrate

BF-HAD

BF-HAD + BF-TE
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Carbamoyl
phosphate
Imidodiphosphate
Acetylphosphate
Glycerolphosphate

kcat
-1
(s )

Km
(µM)

kcat /Km
-1 -1
(M s )

kcat
-1
(s )

Km
(µM)

kcat /Km
-1 -1
(M s )

(4.1 ± 0.3) x 10-2

(9.7 ± 0.8) x 102

4.2 x 101

(4.3 ± 0.1) x 10-2

(9.1 ± 0.8) x 102

4.7 x 101

(3.8 ± 0.2) x10-1

(7.4 ± 0.5) x 103

5.1 x 101

(4.0 ± 0.3) x10-1

(8.2 ± 0.5) x 103

4.9 x 101

(2.0 ± 0.1) x 10-2

(8.7 ± 0.6) x 102

2.3 x 101

(2.2 ± 0.1) x 10-2

(9.2 ± 0.6) x 102

2.4 x 101

(1.1 ± 0.1) x 10-2

(6.3 ± 0.2) x 101

1.7 x 102

(1.1 ± 0.1) x 10-2

(5.9 ± 0.2) x 101

1.9 x 102

2.4 Conclusion
In the study described above the fusion proteins, PG1653 and BF1314 were shown
to catalyze the hydrolysis of DHN-CoA to CoASH and DHN as a step in the menaquinone
(vitamin K12). The DHN-CoA was biosythnesized by from synthetic OSB by the coupled
reactions of OSB: CoA ligase and DHN-CoA synthase. Both PG1653 and BF1314
exhibited high catalytic efficiency in the hydrolysis of DHN-CoA. The BF1314 was found
to have very weak phosphatse activity and the N-terminal HAD domain of PG1653 had
none. The truncated HAD domain of BF1314 is able to dephosphorylate glycerol
phosphate with kcat/Km=1.2 x 103 M-1 s-1 at pH 5.5. The truncated thiosterase domain of
PG1653 was prone to precipatation wherease the truncated BF1314 thioesterase domain is
stable and soluble in aqueous buffer. Nieghter truncate was catalytically active, which
might be explained by the fact that they are monomeric and thus do not have a complate
active site. Because the fusion protein is a tetramer we believe that the HAD domain
functions as the oligomerization domain. This would require that it use both the cap and
catalytic domain for oligerimization and this in turn might explain the low phosphatase
activity. Noteably, the standalone DHN-CoA thioesterase from Bacteroides vulgatus (see
Chapter 3) was found to be an octomer. The fusion protein is a product of a mutation
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which fused adjacent HAD and thioesterase domians. The fact that the HAD domain is not
required as a phosphatase is indicated by the loss of the essential acid/base in PG1653.
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Chapter 3. Structure-function Analyses of HAD Phosphatase BT3352 and Hotdogfold Thioesterase BVU_2420

3.1 Introduction
In Chapter 2 I described the 2-domain fusion protein that functions as a 1,4dihydroxynapthoyl-CoA thioesterase (DHN-CoA thioesterase) in the menaquinone
biosynthetic pathway in Bacteriodes thetaiotamicron (BF1413) and the HAD domainthioesterase domain fusion protein. The N-terminal domains of these two fusion proteins
belong to the haloalkanoate dehalogenase (HAD) enzyme superfamily whereas the Cterminal domains which are responsible for the thioesterase activity belong to the hotdogfold enzyme superfamily. The two fusion proteins proved to be poor subjects for structure
determination. Moreover, the HAD domain displayed little to no phosphatase activity. So
that I might carry out structure function analysis of the respective domains their closest
sequence homologues were prepared for study. In this Chapter I report on the structure
and function of the HAD phosphatase BT3352 from B. thetaiotamicron and on the
oligomerization state and kinetic properties of the hotdog-fold thioesterase BVU2420
from Bacteroides vulgatus.

3.2 Materials and Methods
3.2.1 Gene Cloning, Expression, and Purification of Wild Type and Mutant BT3352
HAD Proteins
The gene encoding the BT3352 was amplified from the B. thetaiotaomicron
genomic DNA by PCR and then cloned into the pET-28a vector, which adds a His6 tag to
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the protein N-terminus. Oligonucleotide primers containing the restriction endo-nuclease
cleavage sites NdeI and HindIII, were used in the PCR reactions. Recombinant plasmids
(pET28/BT3352) were isolated by using a Qiaprep Spin Miniprep Kit. Gene sequencing
was carried out at the Center for Genetics in Medicine, University of New Mexico School
of Medicine.
Gene expression was induced in transformed BL21(DE3) competent cells grown
for 6 h in 3 L of LB media containing 50 μg/mL Kanamycin a (37 °C with mixing at 220
rpm) using 1 mM isopropyl-1-thio-β-D-galactopyranoside. Following incubation for 12 h
at 20 °C and 170 rpm, the cells were harvested by centrifugation (6500 rpm for 15 min at
4 °C), resuspended in 300 mL of lysis buffer (50 mM HEPES, 500 mM NaCl, 10 mM
imidazole, 1 mM DTT, pH 8.0) and lysed by two passages through a French Press cell
(12,000 psi). The cell debris was removed by centrifugation at 20,000 rpm for 60 min at 4
°C, and the supernatant containing BT3352 was passed through a Ni+2 affinity column.
The column was washed with 200 mL of lysis buffer and 200 mL of wash buffer (50 mM
HEPES, 500 mM NaCl, 20 mM imidazole, 1 mM DTT, pH 8.0) before BT3352 was
subsequently eluted using 100 mL of the elution buffer (50 mM NaH2PO4, 600 mM
NaCl, 250 mM imidazole, 1 mM DTT, pH 8.0). The protein solution was concentrated by
using a 10 kDa Macrosep centricon (Pall Filtron) device. The imidazole was removed by
dialysis in 50 mM HEPES, 300 mM NaCl, pH 7.5. The purity of the protein was verified
by using SDS-PAGE. The protein concentration was determined by using the Bradford
method and by measuring the absorbance at 280 nm ( = 20359 M-1 cm-1).
The selenomethionine substituted protein was expressed in E. coli B834(DE3) cells
transformed with pET28/BT3352. The protein was purified at 4 oC using Ni-NTA column
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chromatography followed by size exclusion S-200 column chromatography. The protein
was concentrated by utilizing a 10 kDa Macrosep centricon (Pall Filtron) device to give a
final concentration of 21 mg/mL.
Site-directed mutants were prepared by employing a Quickchange Site-Directed
mutagenesis kit from Stratagene with the pET28/BT3352 clone serving as the template in
conjunction with custom-designed commercial primers in the PCR reaction. The mutated
plasmid was used to transform competent BL21(DE3) cells which were then grown in LB
media. The mutant proteins were purified using the same procedure described for the wild
type protein.

3.2.2 Gene Cloning, Expression, and Purification Wild-Type and Mutant BVU2420
The gene encoding BVU2420 was amplified by PCR using Bacteroides vulgatus
genomic DNA and cloned into the pET-28a vector, which adds a His6 tag to the protein
N-terminus. Oligonucleotide primers containing NdeI and HindIII cleavage sites were
used in the PCR reactions. Plasmid DNAs were purified using a Qiaprep Spin Miniprep
Kit. The gene sequencing was carried out at the Center for Genetics in Medicine,
University of New Mexico School of Medicine.
Gene expression was performed using transformed E. coli BL21(DE3) cells.
Following growth in 3 L of LB media (1x) containing 50 μg/mL Kanamycin at 37 °C for
6 h with mixing at 220 rpm, induction was initiated with the addition of 0.2 mM
isopropyl-1-thio-β-D-galactopyranoside. After incubation for 12 h at 20 °C 170 rpm, the
cells were harvested by centrifugation (6500 rpm for 15 min at 4 °C), resuspended in 90
mL of lysis buffer (50 mM HEPES, 300 mM NaCl, 10 mM imidazole, pH=8.0) and lysed
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by 2 passages through a French Press cell (12,000 psi). The cell debris was removed by
centrifugation at 20,000 rpm for 60 min at 4 °C, and the supernatant containing
BVU2420 was passed through a Ni+2 affinity column for His6-tagged protein binding.
The column was washed with 200 mL of lysis buffer and 100 mL of wash buffer (50 mM
HEPES, 300 mM NaCl, 20 mM imidazole, pH 8.0) before the BVU2420 was
subsequently eluted using 100 mL of elution buffer (50 mM HEPES, 300 mM NaCl, 250
mM imidazole, pH 8.0). The protein solution was concentrated to ~30 mL by using a 10
kDa Macrosep centricon (Pall Filtron) device. To remove the His6-tag, 30 L of thrombin
(500U/mL) were added to the concentrated protein solution at room temperature (25 °C)
and the resulting solution was incubated overnight and then passed through a Ni+2 affinity
column. The eluate was dialyzed at 4 oC in 50 mM HEPES and 100 mM NaCl (pH 7.5).
The protein purity was verified by SDS-PAGE. The protein concentration was
determined by the Bradford method and by measuring the absorption at 280 nm.

3.2.3 Steady-State Kinetic Measurements
The rate of enzyme catalyzed hydrolysis of p-nitrophenyl phosphate (PNPP)
hydrolysis was determined by monitoring the increase in absorbance at 410 nm (∆ = 18.4
mM-1cm-1) at 25 °C or 37 °C. The 0.5 mL assay mixtures contained 50 mM HEPES (pH
7.0) and 5 mM MgCl2. Hydrolysis reactions of all other phosphate esters were monitored
using the Enzcheck phosphate assay kit (Invitrogen).The phosphate release in solutions
containing 20 mM Tris-HCl, 2 mM MgCl2, and 2 mM sodium azide (pH 7.5) was
monitored at 25°C by measuring the increase in absorbance at 360 nm. Initial velocities of
the reactions were measured as a function of substrate concentrations, which were varied in
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the range of 0.5 to 10-fold KM. The initial velocity data were fitted using equation 1 and the
computer program KinetAsyst to define Vmax and KM. The kcat values were calculated from
the ratios of Vmax and enzyme concentrations.
V = Vmax[S]/([S] + KM)
where V is the initial velocity, Vmax the maximum velocity, [S] the substrate concentration,
Km the Michaelis constant.
Thioesterase activity was measured using the DTNP coupling assay. The reaction
solutions (1 mL) contained specified concentrations of substrate and 1 mM DTNB in 0.15
M KCl and 50 mM K+HEPES (pH 7.5). The progress of the reaction was monitored at 412
nm. The initial velocity of the reaction was measured as a function of the concentration of
the substrates, varied in a range of 0.5 to 10-fold KM. The initial velocity data were fitted
with the enzyme kinetic module in Sigmaplot to define Vmax and KM. The kcat was
calculated from the ratio of Vmax and enzyme concentration.
V = Vmax[S]/([S] + KM)
where V is the initial velocity, Vmax the maximum velocity, [S] the substrate
concentration, Km the Michaelis constant.

3.2.4 Size exclusion chromatography
SEC was performed on ÄKTA P-920 FPLC system and Hiprep 16/60 Sephacryl
S-200 HR column (GE Healthcare). The size exclusion column was equilibrated with 50
mM HEPES (pH 7.5), 500 mM NaCl, and 1 mM DTT. The column was calibrated using
the gel-filtration low molecular weight and high molecular weight gel filtration
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calibration kit from Amersham Biosciences. Purified protein (2 mL, ca. 200 mM) was
applied to the column.

3.2.5 BT3352 Crystallization
The crystallization and X-ray structure determination of BT3352 were carried out
in Dr. Karen Allen’s laboratory at Boston University. Crystals of BT3352 were initially
obtained using the Index HT screen (Hampton Research) in 200 mM NaCl, 100 mM BisTris buffer (pH 6.5) and 25% PEG 3,350. The crystallization condition was optimized by
employing the vapor diffusion method with hanging drop geometry and using the
Additive Screen (Hampton Research). Final conditions, using 2 µl drops comprised of
equal amounts (1 µL each) of 25 mg/mL protein equilibrated against a reservoir solution
containing 100 mM Bis-Tris buffer, pH 6.5, 200 mM NaCl, 28% PEG 3350 and 30 mM
Gly-Gly-Gly, yielded crystals in ca. 2-3 d (figure 3.2). A solution containing 5 mM
sodium tungstate and 5 mM magnesium chloride was added directly to the hanging drop
containing the crystals and incubated for 5 min, before the crystals were dragged through
Paratone (which caused clusters to break into single crystals). A single crystal was
abstracted using a loop and directly frozen in the LN2 stream. The crystal belonged to the
space group P212121 with unit cell dimensions of a = 34.913 Å, b = 66.744 Å, c = 97.615
Å. Data were collected at a wavelength of 1.2134 Å optimized for tungsten anomalous
edge at BeamLine X12C at NSLS of BNL, Upton, NY, which is equipped with a
Brandeis 2 x 2 CCD detector (Figure 3.2).
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Figure 3.1. BT3352 crystals. Optimized crystals of BT3352 (left panel), oscillation
photo of tungstate bound BT3352 at λ = 1.2134 Å (right panel).

3.2.6 BT3352 X-ray Structure Determination
The structure of BT3352 was determined at 1.99 Å using phases calculated by
using the SAD method from a single tungsten atom (as tungstate (WO4)). Phenix AutoSol
was used to determine the heavy atom site (Hyss), calculate phases (Phaser), perform
density modification (Resolve) and build a partial model (130 of 270 residues) (10).
Phenix AutoBuild was used to build the remaining residues of the model of BT3352 (267
of 270 residues). Iterative rounds of manual refinement in COOT (11) and of atomic
position, atomic displacement factor and simulated annealing refinement were carried out
in Phenix Refine (12) until an acceptable R factor and Rfree were obtained.

Table 3.1. Data Collection, Phasing and Refinement Statistics for the BT3352 apo
structure with Mg2+ as a cofactor and tungstate.
Data Statistics
Space group

P212121

Cell dimension (Å)

a = 34.913 b = 63.744 c =
75

97.615
Molecules / ASU

1

Wavelength (Å)

1.2134

Resolution (Å)

1.99

Observed reflections

273,888

Unique reflections

27,423

Completeness (%)

94.8 (97.9)

Rmerge (%)

11.8 (31.8)

<I/σ>

22.5(13.6)

Redundancy

5.1 (4.1)

Figure of Merit

0.843

Phase Error

22.59
Refinement

R / Rfree

18.42 / 22.38

Average B Factor (Å2)
protein

21.4

water

25.0

Mg

20.9

WO4

20.4

Rms deviation from ideal Bonds

0.0312

Rms deviation from ideal Angles

1.4215

Ramachandran Plot Statistics favored region

262 (98.2%)

Ramachandran Plot Statistics allowed region

5 (1.8%)

3.3 Results and Discussion
3.3.1 BT3352 Structure Analysis
Mass spectrometric analysis of the recombinant BT3352 shows that the MW of the
protein is 32086.3 Da, which matches with the theoretical MW of 32085.5 Da computed
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by using ExPASy. The native molecular mass determined by size exclusion
chromatography is 21 kDa which indicates that BT3352 is a monomer.
X-ray structure determination and analysis were carried out by Dr. Kelly
Daughtery in Professor Karen Allen’s laboratory at Boston University. The structure of
BT3352, complexed with tungstate (WO4) and magnesium, was solved at 1.99 Å using
tungsten (as WO4) to phase the structure (Table 1). The overall three-dimensional
structure of the protein is similar to that of other HADSF members (Figure 3.3). The
Rossmann fold core domain is conserved and the four conserved motif residues are found
to form the active-site (figure 3.3). Tungstate is observed to be bound in the phosphate
transfer site. BT3352 has a type C2B cap (100 residues), which has a ββββββ
topology inserted between HAD motifs two and three (Figure 3.4) of the Rossmann fold.
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Figure 3.2. BT3352 X-ray crystallographic structure. BT3352 bound with Mg2+ and
tungstate is shown in Pymol as a cartoon diagram (left panel) with HAD motif residues
shown in stick (motif 1 red, motif 2 green, motif 3 cyan, motif 4 orange) and magnesium as
magenta sphere. Zoom in of BT3352 active site with HAD motifs (right panel) oxygen and
water (sphere) are shown in red, nitrogen is shown in blue, and tungsten in light blue.

Figure 3.3. Topological diagram of BT3352. Generated by using TopDraw (13) in
CCP4 (14). Core domain shown in red and cap domain shown in blue. Figure
compliments of Dr. Daughtery.

To determine

if the BT3352 structure determined by using crystallographic

methods is in the cap-open or cap-closed conformation, the catalytic domain of BT3352
was overlayed (by Dr. Kelly Daughtery) with cap-open and cap-closed structures of C2B
family members (closed PDB ID 1RKQ, 1YMQ, open 3MPO, 1NF2) using the Dali
structural alignment server. The structures 3MPO, 1RKQ, 1NF2 and 1YMQ share 31%,
29%, 29% and 25% sequence identity with BT3352 and have an RMSD of 2.4, 2.6, 2.0 Å
and 2.3 Å, respectively. The cap-open structures of 3MPO and 1NF2 overlay well with
BT3352, while the cap closed 1RKQ and 1YMQ structures display cap position
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differences. Thus, the structure BT3352 is considered to be in the cap-open conformation
(Figure 3.5). Because of the comparatively higher sequence identity with BT3352, the
structure of 1RKQ (yidA from E. coli) was used to generate a cap-closed model of
BT3352. The model depicts a solvent excluded active site.

Figure 3.4. BT3352 Cap Analysis. BT3352 (purple) overlayed with 1RKQ (yellow)
(left panel), and the cap-closed model of BT3352 (cyan) overlayed with the BT3352 capopen structure (purple) (right panel). Figure prepared by Dr. Daughtery.
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Figure 3.5. Primary Sequence Alignment of C2B members. Sequence alignments of
BT3352, 3MPO, 1RKQ, 1NF2and 1YMQ (Clustal @ EBI), in which highlighted residues
are proposed specificity residues in C2B members. Bold residues indicate HAD motifs,
(*) indicates absolutely conserved; (:) indicates mostly conserved, (.) indicates somewhat
conserved.

Owing to the lack of liganded structures of C2B family members, it is not
possible to assign specificity residues. However, structural and primary sequence
alignments suggest variable residues in the cap of each enzyme (
Figure 3.6). Variability is seen in a loop between β10 and β11 of the cap across HAD
type 2B family members (BT3352 – Glu 183, 3MPO - Ala, 1RKQ – Ala, 1NF2 – Phe,
1YMQ – Tyr), suggesting their possible importance in specificity. The beta-strands β10
and β11 are part of a structurally conserved beta-sheet in C2B cap domains. Loop
residues are found within non-bonded interaction ranges of the active site of C2B
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members. Lu et. al. proposed that this loop contains specificity residues (termed the
primary specificity loop) (9), a hypothesis which our structural analysis supports.

3.3.2 Substrate Specificity and Docking Models
BT3352 contains the conserved catalytic HAD motifs that are found in all other
HADSF members. Based on the initial broad substrate specificity screen alone, the
physiological substrate of this protein was unclear owing to the low Km and kcat values

Figure 3.6. Substrate docking in BT3352 active site. BT3352 (gray cartoon) with HAD
motifs (according to standard coloring) and possible substrate binding residues in the cap
(yellow). Fructose 6-phosphate (teal) with BT3352 van der Waal surface shown in gray.

measured for a wide range of substrates. In this series, fructose 6-phosphate (kcat / Km =
3.3 x 102 M-1s-1), imidodiphosphate (kcat / Km = 3.1 x 103 M-1s-1) and threonine phosphate
(kcat / Km = 8.2 x 102 M-1s-1) have the highest kcat / Km values, but still are relatively poor
substrates compared to those of other C2B phosphatases (e.g. kcat / Km on the order of 105
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M-1s-1 (4)). This finding indicated that the true substrate probably had not been identified
by using the initial screen. Employing the cap open structure, a van der Waals surface
was generated and a cavity surface of the BT3352 active site was made using PyMOL
(15). These two surfaces were used by Dr. Kelly Daughtery in Professor Karen Allen’s
laboratory at Boston University to manually dock several possible substrates into the
active site by overlaying the substrate phosphoryl moiety with the tungstate ion bound in
the active site. Fructose 6-phosphate fits well into the cap open structure, but it appears to
be too large to be accommodated in the cap closed model (Figure 3.5). This finding
correlates well with the large Km value (Km = 1.4 mM) of fructose 6-phosphate.
Imidodiphosphate and threonine phosphate are both relatively small molecules that do
not reside within hydrogen bonding distance of cap residues when docked in the active
site of cap-closed BT3352. Both compounds are low avtivity substrates for BT3352.
Based on this structural analysis, it appeared that a feasible substrate for BT3352 could
be a 4 or 5 carbon phosphorylated sugar. As a result, kinetic studies were carried out with
4 and 5 carbon phosphorylated sugars (see below).

Table 3.2. Steady-state kinetic contants measured for BF1314, PG1653, BFHAD and
BT3352 catalyzed hydrolysis of phosphate esters in 20 mM Tris, 1 mM MgCl2, 0.1 mM
sodium azide at pH 7.5 and 25 oC.
Substrate
paraNitrophenyl
phosphate
Carbamoyl
phosphate

Variable
Proteins
BF1314
BFHAD
PG1653
BT3352

kcat
(s-1)
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
(1.5 ± 0.1) x 10-3

Km
(µM)
---------------------(4.4 ±0.5) x 102

Km/kcat
(M-1s-1)
---------------------3.3

BF1314
BFHAD
PG1653
BT3352

(2.4 ± 0.1) x 10-2
(3.5 ± 0.3) x 10-2
< 1 x 10-4
(4.6 ± 0.4) x 10-2

4.4 ± 0.3) x 102
(9.8 ± 0.8) x 102
-------(1.5 ± 0.1) x 103

5.4 x 101
3.6 x 101
-------3.1 x 101
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Imidodi
phosphate
Uridine mono
phosphate
(UMP)
Adenosine
mono
phosphate
(AMP)
Glycerol
phosphate
Thiamine
phosphate
Threonine
phosphate
Farnesyl
monophophate
Farnesyl
pyrophophate
Serinol
phosphate
Erythrose 4phosphate
Glyceraldehye
3-phosphate
6-phospho
gluconic acid
3-phospho
glycerate
2-phospho
glycolate

BF1314
BFHAD
PG1653
BT3352
BF1314
BFHAD
PG1653
BT3352
BF1314
BFHAD
PG1653
BT3352
BF1314
BFHAD
PG1653
BT3352
BF1314
BFHAD
PG1653
BT3352
BF1314
BFHAD
PG1653
BT3352
BF1314
BF-HAD
PG1653
PGF11D
BF1314
BF-HAD
PG1653
PGF11D
BF1314
BFHAD
PG1653
BT3352
BF1314
BFHAD
PG1653
BT3352
BF1314
BFHAD
PG1653
BT3352
BF1314
BFHAD
PG1653
BT3352
BF1314
BFHAD
PG1653
BT3352
BF1314
BFHAD
PG1653

(2.1 ± 0.1) x 10-1
(2.0 ± 0.2) x10-1
< 1 x 10-4
(2.0 ± 0.1) x 10-1
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
(1.1 ± 0.1) x 10-2
< 1 x 10-4
(8.5 ± 0.1) x 10-1
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
(8.8 ± 0.3) x 10-1
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
(7.9 ± 0.2) x 10-1
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
(1.8 ± 0.1) x 101
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
(3.3 ± 0.1) x 10-1
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
(1.1 ± 0.1) x 10-2
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
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(5.7 ± 0.7) x 103
(7.4 ± 0.8) x 103
-------(6.2 ±0.2) x 101
--------------------------------------------------------(6.3 ± 0.2) x 101
-------(2.7 ± 0.2) x 103
-------------------------------------------------(1.1 ± 0.1) x 103
-----------------------------------------------------------------------------(1.3 ± 0.1) x 103
---------------------(1.4 ± 0.1) x 102
---------------------(2.7 ± 0.2) x 103
---------------------(9.4 ± 0.9) x 103
--------------------------------------------------

3.7
2.7
-------3.2 x 102
---------------------------------------------------------------1.7 x 102
-------3.1 x 102
-------------------------------------------------8.2 x 102
-----------------------------------------------------------------------------6.2 x 102
---------------------1.3 x 105
---------------------1.2 x 102
---------------------1.1
--------------------------------------------------

PEP

Fructose 6phosphate
Glucose 6phosphate
2-keto-3deoxy6-phospho
galactonate

BT3352
BF1314
BFHAD
PG1653
BT3352
BF1314
BFHAD
PG1653
BT3352
BF1314
BFHAD
PG1653
BT3352
BF1314
BFHAD
PG1653
BT3352

(9.2 ± 0.5) x10-1
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
(4.6 ± 0.1) x 10-1
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4
< 1 x 10-4

(1.1 ± 0.1) x 103
-------------------------------------------------(1.4 ± 0.1) x 103
---------------------------------------------------------

8.2 x 102
-------------------------------------------------3.3 x 102
---------------------------------------------------------
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0.000
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1/[D-erythrose-4-phosphate] (uM-1)
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Figure 3.7. Lineweaver-Burk plot of the BT3352 catalyzed erythrose 4-phosphate
hydrolysis reaction (20 mM Tris, 1 mM MgCl2, 0.1mM sodium azide, pH 7.5, 25 oC)

The results of a four and five carbon phosphorylated sugar substrate screen
indicate that erythrose 4-phosphate is the best substrate of BT3352 with a kcat / Km = 1.3
x 105 (figure 3.8). The low Km (Km = 140 µM) of this substance indicates that it could be
the physiological substrate of BT3352. Moreover, the substrate range of BT3352 is
narrow and the kcat/Km values of alternate substrates are not physiologically relevant.
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The BT3352 is not located within an operon, however there are two notable genes in the
neighborhood; BT3361, a putative erythronate-4-phosphate dehydrogenase and BT3356 a
predicted 6-phosphofructokinase.

3.3.3 Evolution of the C2B HAD Phosphatases in B. thetatiotaomicron
In total, four C2B HAD phosphatases were identified by using a BLAST search of
the B. thetaiotaomicron genome, including BT1666, BT3352, BT4131 and BT4699 (the
HAD domain-thioesterase domain fusion protein described in Chapter 2). An alignment
of their sequences is shown in Figure 3.9. BT1666 and BT4131 share a relatively high
sequence identity (37%) and, consequently, are likely to be related via a gene duplication
event. BT3352 and the HAD domain of BT4699 share 48% sequence identity, indicating
that they too are likely to be related by a gene duplication event. Following gene
duplication one of the two paralogous gene fused with the gene encoding the DHN-CoA
thioesterase. The redundancy of the fused HAD domain allowed it to evolve a new
function which we have proposed in Chapter 2 is that of a dimerization domain.
BT1666 (21) and BT4131 (9) have been shown be broad specificity, low catalytic
efficiency phosphatases, with kcat/Km values for sugar phosphate substrates in the range of
1 x 102-1 x 103 M-1 s-1. These two HAD members are likely to function in limiting the
accidental accumulation of sugar phosphate metabolites and thereby protect the cell from
their inhbitory effects on off target enzymes. In contrast, BT3352 functions as a highly
specific erythrose 4-phosphate phosphatase with comparatively high catalytic efficency. It
might function to hydrolyze erythrose 4-phosphate or its oxidation product erythronate-4phosphatase (kcat/Km = 2 x 103 M-1s-1).
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Figure 3.8. Primary sequence alignment of B. thetaiotaomicron C2B members. The
coloring and labeling patterns are the same as those used in Figure 3.6.

3.3.4 Divergence in Structure and Function in Homologues B. thetaiotaomicron
BT3352 and E. coli yidA

86

Table 3.3. Steady-state kinetic constants kcat and Km for wild-type and mutant BT3352
catalyzed hydrolysis of erythrose 4-phosphate in 20 mM Tris, 1 mM MgCl2, 0.1 mM
sodium azide, pH 7.5, 25 oC.

BT3352

kcat
(s-1)

Km
( µM)

kcat/Km
(M-1s-1)

yidA

kcat
(s-1)

Km
(µM)

kcat/Km
(M-1s-1)

WT

(1.8 ± 0.1) x 101

(1.4 ± 0.1) x102

1.2 x 105

WT

8±1

(4.2 ± 0.1) x 102

1.9 x 104

R46A

<10-4

--------

--------

R46A

(1.6 ± 0.08) x 10-2

(4.0 ± 0.4) x 102

4.0 x 101

E128A

(4.4 ± 0.2) x 10-2

(1.9 ± 0.2) x 103

2.3 x 101

E130A

(8.0 ± 0.3) x 10-2

(2.6 ± 0.2) x 102

3.1 x 102

K152A

(2.6 ± 0.1) x 10-2

(3.9 ± 0.6) x 102

6.6 x 101

K154A

(7.8 ± 0.2) x 10-2

(4.2 ± 0.3) x 102

1.9 x 102

L154A

2.3 ± 0.1

(1.2 ± 1.3) x 103

1.9 x 103

M156A

(1.3 ± 0.6) x 101

(1.5 ± 0.2) x 103

8.2 x 103

S182A

(2.3 ± 0.1) x 10-1

(7.1 ± 0.2) x 102

3.2 x 102

S184A

1.60 ± 0.04

(3.6 ± 0.2) x 102

4.4 x 103

Y185A

(4.8 ± 0.2) x 10-1

(3.6 ± 0.4) x 102

1.3 x 103

Y187A

(2.2 ± 0.02) x 10-1

(8.0 ± 0.2) x 101

2.8 x 103

F186A

(9.1 ± 0.3) x 10-2

(3.8 ± 0.3) x 102

2.4 x 102

F188A

5.0 ± 0.2

(4.8 ± 0.3) x 102

1.8 x 104

E188A

(3.7 ± 0.1) x 10-2

(7.6 ± 0.6) x 102

4.8 x 101

E190A

(4.6 ± 0.1) x 10-1

(1.4 ± 0.1) x 103

3.4 x 102

The active site residues of special interest in these enzymes include Arg45, Glu128,
Lys152, Leu154, Ser182, Tyr185, Phe186 and Glu188. Arg45 is conserved among HADSF
members. Also, Ala replacement of the Asp11 acid/base partner Arg46 leads to a reduction
of the activity of BT3352 to below the detection limit (Table 3). Lu et al. proposed that as
general base, Asp11 is held in position by a hydrogen bond formed with the side chain of
Arg45 (20). The other important residues may play important roles in substrate recognition.
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L154
F188

Y185
Y187

E128
S182

E188

M156
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S184

E130
E190

K154

R45
R46

Figure 3.9. Pymol generated stereoview of the zoom-in structures of BT3352 (left) and
yidA (right) with active sites showing the amino acid residues that immediately surround
docked erythrose 4-phosphate.

Table 3.4. Comparisons of the phosphatase activities of BT3352 and yidA towards a
variety of substrates in 20 mM Tris, 1 mM MgCl2, 0.1 mM sodium azide, pH 7.5, 25 oC.
Substrate
paraNitrophenyl
phosphate
Glycerol
phosphate
Erythrose 4phosphate
erythronate 4phosphate
Ribose 5phosphate
Ribulose 5phosphate
Arabinose 5phosphate
Fructose 6phosphate
Fructose 1phosphate

kcat
(s-1)

BT3352
Km
(µM)

Km/kcat
(M-1s-1)

kcat
(s-1)

yidA
Km
(µM)

Km/kcat
(M-1s-1)

(1.5 ± 0.1) x 10-3

(4.4 ±0.5) x 102

3.3

(3.5 ± 0.1) x 10-3

(2.2 ±0.1) x 103

1.7 x 101

(8.5 ± 0.1) x 10-1

(2.7 ± 0.2) x 103

3.1 x 102

1.0 ± 0.1

(3.7 ±0.5) x 103

2.7 x 10-1

(1.8 ± 0.1) x 101

(1.4 ± 0.1) x 102

1.3 x 105

8.0 ± 1.0

(4.2 ± 0.1) x 102

1.9 x 104

1.8 ± 0.1

(2.0 ± 0.2) x 102

9 x 103

1.0 ± 0.1

(1.0 ± 0.1) x 102

1 x 104

1.1 ± 0.1

(1.5 ± 0.2) x 103

7.3 x 102

8.4 ± 0.5

(1.1 ± 0.1) x 104

8.1 x 102

(6.3 ± 0.1) x 10-1

(2.1 ± 0.1) x 103

3.0 x 102

7.0 ± 0.5

(5.8 ± 0.5) x 103

1.2 x 103

(6.3 ± 0.1) x 10-1

(1.0 ± 0.1) x 103

6.3 x 102

(1.4 ± 0.4) x 101

(2.2 ± 0.2) x 103

6.5 x 103

(4.6 ± 0.1) x 10-1

(1.4 ± 0.1) x 103

3.3 x 102

3.8 ± 0.2

(6.6 ± 0.7) x 103

5.8 x 102

< 1 x 10-4

--------

--------

1.5 ± 0.1

(2.7 ± 0.2) x 104

5.4 x 102
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Mannose 6phosphate
Galactose 1phosphate
Glucose 6phosphate
Glucose 1phosphate
2-keto-3-deoxy6-phospho
galactonate
6-phospho
gluconic acid

< 1 x 10-4

--------

--------

6.3 ± 0.8

(3.7 ± 0.3) x 104

1.7 x 102

< 1 x 10-4

--------

--------

(3.6 ± 0.3) x 10-1

(2.5 ± 0.2) x 104

1.4 x 101

< 1 x 10-4

--------

--------

6 ± 0.6

(2.1 ± 0.3) x 104

2.9 x 10-1

< 1 x 10-4

--------

--------

4.2 ± 0.1

(2.7 ± 0.2) x 103

1.5 x 103

< 1 x 10-4

--------

--------

1.6 ± 0.1

(2.5 ± 0.4) x 102

6.4 x 103

(1.1 ± 0.1) x 10-2

(9.4 ± 0.9) x 103

1.1

(1.4 ± 0.1) x 10-1

(9.2 ± 0.8) x 103

1.6

In order to obtain a “virtual” picture of the catalytic site in the enzyme-substrate
complex, erythrose 4-phosphate was docked into BT3352. The resulting model shows that
one of the substrate’s hydroxyl groups is located within hydrogen bonding distance of the
side chains of E128 (3.0 Å) and E188 (3.3 Å) (Figure 3.11). In comparison, E130 (3.0 Å)
and E190 (4.3 Å) of yidA participate in long hydrogen bonding interactions with erythrose
4-phosphate, an observation, which indicates the existence of a larger active site that can
accommodate larger substrates. The substrate screen results (Table 3) also demonstrated
that yidA has a more roomy active site that can accommodate a wide substrate group
ranging from tetrose to hexose phosphate. In contrast, the active site of BT3352 appears to
be more compatible with substrates like tetrose and pentose phosphate.
Wild type BT3352 is 10-fold more active in the hydrolysis of erythrose 4-phosphate
than is yidA and it displays a greater sensitivity to the mutations. A zoom-in snapshot of
the catalytic site reveals that BT3352 provides more residues for interaction with the
hydroxyl groups of erythrose 4-phosphate, an observation which may account for the 3-fold
lower Km of BT3352 in contrast to that of yidA (Figure 3.11).
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F186
E128
E188

S182
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E130
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K154

K152
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R46

S184

R46

Figure 3.10. A Pymol generated stereoview of the hydrogen bonding patterns between
the active sites of BT3352 (A), and yidA (B) and erythrose 4-phosphate.

Mutations in the caps of both BT3352 and yidA have a greater impact on kcat than
on Km, with the exception of the L154A/M156A double mutation which leads in BT3352
to a 10-fold increase in Km and an 8-fold decrease in the kcat. In contrast there is little
change in the yidA kcat. The biggest effects on catalytic activity are promoted by the
following mutations of the three charged residues: E188A/E190A, E128A/E130A, K152A
/K154A. The S182A/S184A mutation causes a large effect on the activity of BT3352 (300fold decrease kcat/Km) and only a small effect on that of yidA (4-fold decrease). Similarly,
the F186A/F188A mutation reduces the kcat/Km of the BT3352 500-fold but does not affect
the kcat/Km of yidA. The Y185A/Y187A mutation has a 10-fold greater effect on the
catalytic efficiency of BT3352 than that of yidA. In addition to the effects on catalytic
efficiency, replacement of S182, Y185, and F186 with Ala leads to a great destabilization
of BT3352, while the corresponding mutations S184A, Y187A, and F188A have no
noticable effect on the stability of yidA. Overall, yidA is less efficient and less responsive
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to mutations. Nevertheless, the sensitivity of kcat to the cap mutations suggests that the
interaction between the cap and catalytic domains is important to productive binding and/or
transition state stabilization.

Table 3.5. Steady-state kinetic constants kcat and Km for BT3352 mutants L154A and
L154M for hydrolysis of erythrose-4-phosphate in 20 mM Tris, 1 mM MgCl2, 0.1mM
sodium azide, pH 7.5, 25 oC.
Substrate
erythrose
4-phosphate
α glucose 1phosphate
2-keto-3-deoxy6-phospho
galactonate

kcat
(s-1)

L154A
Km
(µM)

Km/kcat
(M-1s-1)

kcat
(s-1)

L154M
Km
(µM)

Km/kcat
(M-1s-1)

2.3 ± 0.1

(1.2 ± 1.3) x 103

1.9 x 103

(6.8 ± 0.2) x10-1

(7.1 ± 0.5) x102

9.6 x 102

< 1 x 10-4

--------

--------

< 1 x 10-4

--------

--------

< 1 x 10-4

--------

--------

< 1 x 10-4

--------

--------

The active site residues L154 in BT3352 and M156 in yidA may play roles in the
determining the active site environment. Mutagenesis of both L154 and M156 to alanine
results in significant decreases in Km values (10-fold for BT3352 and 4-fold for yidA).
Mutation of L154 to Met does not greatly change the specificity or activity of BT3352 (Km
is decreased 5-fold and the kcat decreased 30-fold; Table 5). Mutation of Phe186, Glu128
and Glu188 to Ala results in significant changes in BT3352’s specificity as demonstrated
by the observation that 2-keto-3-deoxy-6-phosphogluconate (KDPG) and 2-keto-3-deoxy6-phosphogalaconate (KDPGal) are good substrates for the mutants but not for the wildtype enzyme. In comparison to the activity of wild type BT3352 for hydrolysis of KDPG,
the Km of E128A decreased 3-fold and the kcat is increased 400-fold (kcat/Km value of 2.3 x
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104 M-1s-1). The KDPG Km of E188A is decreased 30-fold but the kcat is decreased 5-fold.
Finally, the E128A mutant also shows modest phosphatase activity for KDPGAL (Table
3.6).

Table 3.6. Steady-state kinetic constants kcat and Km for wild-type and mutant BT3352
catalyzed hydrolysis of 2-keto-3-deoxy-6-phosphogluconate (KDPG) and 2-keto-3deoxy-6-phosphogalaconate (KDPGal) in 20 mM Tris, 1 mM MgCl2, 0.1 mM sodium
azide, pH 7.5, 25 oC)
KDPG

KDPGal

kcat
(s-1)

Km
( µM)

kcat/Km
(M-1s-1)

kcat
(s-1)

Km
(µM)

kcat/Km
(M-1s-1)

WT

(1.3 ± 0.1) x 10-2

(5.9 ± 0.4) x102

2.2 x 101

<10-4

--------

--------

R46A

<10-4

--------

--------

<10-4

--------

--------

E128A

4.8 ± 0.1

(2.1 ± 0.1) x 102

2.3 x 104

2.1 ± 0.1

(1.0 ± 0.1) x 103

2.0 x 103

K152A

<10-4

--------

--------

<10-4

--------

--------

L154A

<10-4

--------

--------

<10-4

--------

--------

L154M

<10-4

--------

--------

NA

S182A

<10-4

--------

--------

<10-4

--------

--------

Y185A

<10-4

--------

--------

<10-4

--------

--------

F186A

(2.1 ± 0.1) x 10-1

(5.9 ± 0.3) x 103

3.6 x 101

(3.7 ± 0.1) x 10-2

(7.5 ± 0.4) x 102

4.9 x 101

E188A

(6.9 ± 0.3) x 10-2

(2.2 ± 0.2) x 101

3.1 x 103

(5.8 ± 0.1) x 10-2

(1.0 ± 0.1) x 103

5.8 x 101

The HAD subfamily IIB cap domains can be subclassified into small (αββαββ) or
large (αββ(αβαβ)αββ) domain groups. The large domain family contain an αβαβ insertion
of a small domain by using two loops to cover the core domain. The αββαββ loop is
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utilized for determining primary substrate specificity whereas the αβαβ loop is the
secondary substrate specificity domain. Both BT3352 and yidA contain primary (residues
180-190 in BT3352 numbering and residues 182-192 in yidA numbering) and secondary
(residues 122-133 in BT3352, and 124-135 in yidA) substrate specificity loops. The results
of mutagenisis experiments demonstrate that these loops act to position the polar residues
Glu188/Glu190 on their primary substrate specificity loops and Glu128/Glu130 on their
secondary loops to accommodate the polar leaving groups in hydrolysis reactions.

3.3.5 Native molecular weight of BT3352 and BVU_2420
Size exclusion chromatography was carried out to determine the native molecular
weight BT3352 and BVU_2420 (Figure 3.12; Table 3.6)). BT3352 is a monomer in
solution whereas BVU_2420 is an octomer.

20.9 kDa
(0.65 x 32.2 kDa)

20.9 kDa
(0.65 x 32.2 kDa)

BVU_24202

BT3352

(a)

(b)
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Figure 3.11 SEC of recombinantly expressed and purified proteins (a)BT3352; (b)
BVU2420.

Table 3.7. Size exclusion chromatography evaluation table
Monomer

Sec

Enzymes

Oligomer
Mw, calc (kDa)

Mw, obs (kDa)

x-merobs

BT3352

32.2

20.9

0.65

monomer

BVU_2420

16.7

130.2

8.3

octomer

3.3.6 Determination of the substrate specificity profile for BVU_2420 and comparison
to those of the HAD-thioesterase fusion proteins BF1314 and PG1653.
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5
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-0.05
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0.10
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1/[DHN-CoA] (µM)

Figure 3.12. Lineweaver-Burk plot of the BVU_2420 catalyzed DHN-CoA hydrolysis in
50 mM HEPES (pH 7.5, 25 oC).
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Table 3.8. Comparison of the substrate thioesterase activity of BF1314, PG1653, and
BVU_2420. The steady-state kinetic constants kcat and Km were measured in 50 mM
K+HEPES (pH 7.5, 25 oC) using the DTNB assay.
Substrate
Butyryl-CoA
IsobutyrylCoA
HexanoylCoA
Octanoyl-CoA
DecanoylCoA
MyristorylCoA
DHN-CoA
NP-CoA
4HBA-CoA
Benzoyl-CoA
3HPA-CoA

Variable
Proteins
PG1653
BF1314
BVU_2420
PG1653
BF1314
BVU_2420
PG1653
BF1314
BVU_2420
PG1653
BF1314
BVU_2420
PG1653
BF1314
BVU_2420
PG1653
BF1314
BVU_2420
PG1653
BF1314
BVU_2420
PG1653
BF1314
BVU_2420
PG1653
BF1314
BVU_2420
PG1653
BF1314
BVU_2420
PG1653
BF1314
BVU_2420

kcat
(s-1)
<10-4
<10-4
(3.5 ± 0.1) x 10-2
<10-4
<10-4
(2.2 ± 0.1) x 10-2
<10-4
<10-4
(4.2 ± 0.2) x 10-2
<10-4
<10-4
(3.2 ± 0.3) x 10-3
<10-4
<10-4
<10-4
<10-4
<10-4
<10-4
(1.0 ± 0.1) x 101
(1.2 ± 0.1) x 101
(1.3 ± 0.1) x 101
6.9 ± 0.2
6.4 ± 0.3
4.6 ± 0.2
4.6 ± 0.1
1.1 ± 0.1
1.2 ± 0.1
(3.0 ± 0.1) x 10-2
(2.4 ± 0.2) x 10-2
(2.8 ± 0.1) x 10-2
(3.1 ± 0.2) x 10-1
(1.9 ± 0.1 ) x 10-1
(3.4 ± 0.1) x 10-2

Km
(uM)
--------------(6.9 ±0.2) x 102
--------------(6.1 ± 0.4) x 102
--------------(3.3 ± 0.3) x 103
--------------(1.7 ± 0.1) x 104
------------------------------------------4.0 ± 0.3
7.0 ± 0.5
(1.5 ± 0.1) x 101
(1.7 ± 0.2) x 102
(2.3 ± 0.4) x 102
(1.8 ± 0.2) x 102
(8.0 ± 0.6) x 102
(2.3 ± 0.2) x 102
(3.3 ± 0.2) x 101
(5.8 ± 0.5) x 101
(8.4 ± 0.8) x 101
(3.1 ± 0.4) x 101
(1.7 ± 0.3) x 102
(4.6 ± 0.4) x 101
(8.1 ± 0.6) x 102

Km/kcat
(M-1s-1)
--------------5.1 x 101
--------------3.6 x101
--------------1.3 x 101
--------------1.9 x 10-1
------------------------------------------2.5 x 106
1.7 x 106
8.7 x 105
4.0 x 104
2.9 x 104
2.5 x 104
5.8 x 103
4.7 x 103
3.6 x 104
5.2 x 102
2.8 x 102
9.0 x 102
2.0 x 103
4.1 x 103
4.2 x 101

Like BF1314 and PG1653, BVU2420 displayed the highest activity towards the
catalyzed the hydrolysis of DHN-CoA: kcat/Km value of 9 x 105 M-1s-1 (Table 3.7 and
Figure 3.12) and a preference for aromatic thioester substrates. In contrast to BF1314 and
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PG1653, BVU2420 showed some activity with short chain fatty acyl-CoA thioester
metabolites.

3.4 Conclusion
The investigation of BT3352 was initiated to gain further insight into why the HAD
domain of the HAD-thioesterase fusion proteins display little to no phosphatase activity
and to obtain a crystal structure of a close homolog. Based on its substrate activity profile
we conclude that BT3352 is a promiscuous phosphatase which based on its X-ray structure
is designed to target small (C4 and C5) sugar substrates. It’s (type C2b) monomeric
structure is in contrast to the tetrameric structure of the HAD-thioesterase fusion protein.
The similarity between the structures of BT3352 and the E. coli enzyme ydiA suggest
common ancestory despite the ability of the ydiA to act on larger sugar phosphate
substrates. Active site residues Asp128/130, and Asp188/190 in BT3352/yidA play
important roles in recognizing and binding substrates. In addition, residues S182/S184,
K152/K154 in BT3352/yidA may be used to orient E188/E190 in appropriate substrate
binding positions. Replacement of Asp128 and Asp188 with Ala enabled BT3352 to
catalyze the dephosphorylation of KDPG and KDPGal with modest efficiency, and thus
behave like BT3352.
The HAD-thioesterase fusion protein thioesterase domain homolog proved to be a
DHN-CoA thioesterase but disspointingly, to also be a poor subject for X-ray stucture
determination. Its high oligeromization state might be the cause. In order to obtain the
structural information that will provide insight into substrate recognition other close
homologues should be pursued in future work.
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Chapter 4. A Genomic Enzymology Approach to the Discovery of a Novel FattyAcid -Oxidation Pathway in Pseudomonas aeruginosa PAO1

4.1 Introduction
Enzymes, which function in a common constitutive metabolic pathway in bacteria
are often encoded by gene operons or if not operons, then by gene clusters. In this manner,
the synthesis of the individual enzymes can be coordinated so that all are present when
needed. Through the process of systematic function determination of neighboring genes it
is often possible to construct a novel metabolic pathway. The first step to be taken is to
use a BLAST search of protein sequence databanks to identify the closest characterized
homolog to each enzyme and hence the ranges of chemistries catalyzed by known
members of the respective enzyme families. Like pieces of a puzzle the investigator tries
to place the profiled enzymes in order to generate what might be a feasible sequence of
reaction types which would could ultimately be linked to the correct starting
materials/products. To test the model in vitro substrate activity testing can be carried out
using the recombinant enzymes and synthetic substrates.
Because a focus of my doctoral work was to discover novel hotdog-fold
thioesterase functions in bacterial systems I was most interested in identifying a novel
chemical pathway in which a hotdog thioesterase participated. Thus my first step was to
identify an uncharacterized hotdog-fold thioesterase whose gene context was suggestive
of a partnership with the protein products of neighboring genes. This was accomplished
using

the

web

server

Superfamily

(http://supfam.cs.bris.ac.uk/SUPERFAMILY/
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index.html) to identify hotdog-fold thioesterase paralogues in genome sequenced bacteria.
I selected the putative thioesterase PA5185 of the human pathogen Pseudomonas
aeruginosa PAO1 as a promising candidate.
In this chapter I report the results from a combined bioinformatic and
experimental analysis of PA51585 and it’s the protein products of its neighboring genes
that support the assignment of novel metabolic pathway in the pathogen Pseudomonas
aeruginosa which is catalyzed by four the encoded enzymes: PA5185 (the putative
hotdog fold thioesterase), PA186 (a putative iron containing alcohol dehydrogenase),
PA1857 (a putative acyl-CoA dehydrogenase) and PA188 (a putative 3-hydroxyacylCoA dehydrogenase). The nature of the types of reactions possible catalyzed by
homologues of these four enzymes suggested that they are functioning in an organic acid
-oxidation pathway. My goal was to define the substrate, intermediates and the product
of the pathway through defining the substrate specificity profiles of the pathway enzymes.

4.2 Materials and Methods
4.2.1 PA5185 Gene Cloning and Expression in E. coli and Recombinant Protein
Purification
The gene encoding the PA5185 (NCBI accession NP253872, Swiss Pro accession:
Q9HU04) was amplified by PCR from Pseudomonas aeruginosa PAO1 genomic DNA
and then subcloned into the pET-28a vector, which adds a His6 tag to the protein Nterminus. Oligonucleotide primers were 5’- A GGA CCG CAT ATG GCG ACC GCC
CCG CGA (PA5185 forward), 5’- G CGA AAG CTT TCA CTG GGC CGA GCT CTG
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AA (PA5185 reverse), which contained the restriction endo-nuclease cleavage sites Nde I
and Hind III. The cloned gene was confirmed by full length DNA sequencing.
Gene expression was performed using BL21(DE3) competent cells. Following
growth in 3 L of LB media (1x) containing 50 μg/mL Kanamycin at 37 °C for 6 h with
mixing at 220 rpm, induction was initiated with the addition of 0.2 mM isopropyl-1-thioβ-D-galactopyranoside. After incubation for 12 h at 20 °C and 170 rpm, the cells were
harvested by centrifugation (6500 rpm for 15 min at 4 °C), resuspended in 90 mL of lysis
buffer (50 mM HEPES, 300 mM NaCl, 10 mM imidazole, pH 8.0) and lysed by 2
passages through a French Press cell (12,000 psi). The cell debri was removed by
centrifugation at 20,000 rpm for 60 min at 4 °C, and the supernatant containing PA5185
was passed through a Ni+2 affinity column for His6-tagged protein binding. The column
was washed with 200 mL of lysis buffer and 100 mL of wash buffer (50 mM HEPES,
300 mM NaCl, 20 mM imidazole, pH 8.0) before PA5185 was subsequently eluted using
100 mL of elution buffer (50 mM HEPES, 300 mM NaCl, 250 mM imidazole, pH 8.0).
The protein solution was concentrated by using 10 kDa Macrosep centricon (Pall Filtron)
device.
The His6-tagged PA5185 (5 mL, 3.3 mg/mL and pH=7.4)

was digested by

incubating with 30 uL of Thrombin (500 units/mL DDI H2O) at ambient temperature for
12 h. The removal of the His6-tag protein was verified by MS spectroscopy. The protein
solution was dialyzed against 6 L 50 mM HEPES and 300 mM NaCl (pH 7.5) at 4 oC.
The protein purity was verified by SDS-PAGE analysis. The protein concentration was
determined by the Bradford method and by measuring the absorption of the protein
solution at 280 nm ( = 15540 M-1 cm-1).
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4.2.2 Preparation of PA5185 site directed mutants.
The D26A, D26N and D41A PA5185 mutant genes were prepared by using the
quick change mutagenesis kit (Stratgene) in conjunction with the pET-28a/PA5185 clone
as template. Plasmid DNA was purified using the Qiaprep Spin Miniprep Kit. Gene
sequencing was carried out at the Center for Genetics in Medicine, University of New
Mexico School of Medicine.
Gene expression was performed using BL21(DE3) competent cells. Following
growth in 3 mL of LB media (1x) containing 50 μg/mL Kanamycin at 37 °C for 6 h with
mixing at 220 rpm, induction was initiated with the addition of 0.2 mM isopropyl-1-thioβ-D-galactopyranoside. After incubation for 12 h at 20 °C and 170 rpm, the cells were
harvested by centrifugation (6500 rpm for 15 min at 4 °C), resuspended in 90 mL of lysis
buffer (50 mM HEPES, 300 mM NaCl, 10 mM imidazole, pH 8.0) and lysed by 2
passages through a French Press cell (12,000 psi). The cell debri was removed by
centrifugation at 20,000 rpm for 60 min at 4 °C, and the supernatant containing D26A,
D26N or D41A PA5158 was passed through a Ni+2 affinity column. The column was
washed with 200 mL of lysis buffer and 100 mL of wash buffer (50 mM HEPES, 300
mM NaCl, 20 mM imidazole, pH 8.0) before elution with 100 mL of elution buffer (50
mM HEPES, 300 mM NaCl, 250 mM imidazole, pH 8.0). The protein solution was
concentrated by using a 10 kDa Macrosep centricon (Pall Filtron) device and then
dialyzed at 4 oC against 50 mM HEPES and 300 mM NaCl (pH 7.5). The protein purity
was verified by SDS-PAGE analysis. The protein concentration was determined by the
Bradford method and by measuring the absorption at 280 nm.
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4.2.3 Synthesis of 2-keto-3-propanyl-CoA.
A 15 uL (0.6 mmol) aliquoate of acetone bromide was dissolved in 2 mL of
anhydrous THF before adding dropwise to a stirred solution of 50 mg (0.063 mmol) of
CoA (Lithium salt) in 1 mL of deionized water at room temperature. The reaction
solution was maintained at pH 9.0 by adding 0.1 M LiOH or 0.1 M HCl. The mixture was
stirred for 2 h and then was extracted 3 times with 4 mL of ethyl acetate. The water layer
was frozen and lyophilized. The solid was dissolved in 300 µL of deionized water and
then loaded onto a Sephadex G-10 column (95 x 1.5 cm).The column was eluted with
deionized water at room temperature. The 3 mL fractions were analyzed by injecting 50
µL aliquots on to a Rainin Dynamax HPLC system equipted with a reversed-phased C-18
column (Beckmen Ultrasphere), pre-equilibrated with 20% solution B (20 mM
(NH4)2HPO4 in 64% acetonitrile DI water solution, pH 6.7) and 80% solution A (20 mM
(NH4)2HPO4 in DI water, pH 6.7). A linear gradient (20% B 2 minutes, 20~65% solution
B14 min, 65~80% solution B 2 minutes and 20% solution B 2 min) was employed to
elute the column at a flow rate of 1.0 mL/min. The eluant was monitored at 260 nm. The
retention time of the product is 3.3 min. The fractions 19-29 containing pure 2-keto-3propanyl-CoA were pooled and concentrated by lyophilization, the yield is ca.20%, and
the structure was confirmed by 1H NMR and Mass analysis. (500 MHz, D2O): δ 8.63 (s, 1H),
8.36 (s, 1H), 8.41 (s, 1H), 6.24 (d, 1H), 6.22 (d, 1H), 4.92 (d, 2H), 4.91 (d, 2H), 4.64 (s, 1H), 4.28
(s, 2H), 4.06 (s, 1H), 3.87 (t, 1H), 3.86 (t, 1H), 3.85 (t, 1H), 3.61 (d, 1H), 3.60 (d, 1H), 3.58 (s,
3H), 3.51 (s, 2H), 3.36 (s, 2H), 2.64 (s, 2H), 2.51 (s, 2H), 2.26 (s, 3H), 0.94 (s, 3H), 0.81 (s, 3H).

MS: m/z calculated for C24H39N7O17P3S 823.13 compared to the observed mass of 822.14.
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4.2.4 PA5187 and PA5188 Gene Cloning and Expression in E. coli and Recombinant
Protein Purification
The genes encoding the PA5187 and PA5188 (NCBI accession NP253874,
NP253875, Uni Prot accession: Q9HU02, Q9HU01 respectively) were amplified by PCR
from Pseudomonas aeruginosa PAO1 genomic DNA and then subcloned into the pET28a vectors, which add a His6 tag to the protein N-terminus. Oligonucleotide primers
were 5’- AGG TGC GCT CAT ATG GAT TAC CAG GCC CCC (PA5187 forward), 5’GCG AGA AAG CTT TCA GAA CGA GAA ATG CTC (PA5187 reverse), 5’- GAG
GAC AAG CAT ATG AGC CAG AAC TTT TCC (PA5188 forward) and 5’- TGG TAA
AAG CTT TCA GCG CAC CTC CTG CAG (PA5188 reverse), which contained the
restriction endo-nuclease cleavage sites Nde I and Hind III. Subcloned genes were
confirmed by full length DNA sequencing.
Both PA5187 and PA5188 were purified by FPLC. Gene expression was
performed using BL21(DE3) competent cells. Following growth in 3 L of LB media
containing 50 μg/mL ampicillin at 37 °C for 6 h with mixing at 220 rpm, induction was
initiated with 0.2 mM isopropyl-1-thio-β-D-galactopyranoside. After incubation for 12 h
at 20 °C 170 rpm, the cells were harvested by centrifugation (6500 rpm for 15 min at
4 °C), resuspended in 50 mL of binding buffer (20 mM HEPES, 500 mM NaCl, 40 mM
imidazole, pH 7.4) and lysed by a single pass through a French Press cell (12,000 psi).
The cells were removed by centrifugation at 20,000 rpm for 45 min at 4 °C, and the
supernatant containing PA5187 was passed through a GE Histrap FF crude 1 mL column
which had been pre-equilibrate with 5 CV binding buffer (20 mM K+HEPES, 500 mM
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NaCl, 40 mM imidazole, pH=7.4) at 4 oC. The column was washed with 2 CV (10 mL)
binding buffer and then eluted with 5 CV (25 mL) elution buffer (20 mM HEPES, 500
mM NaCl, 500 mM imidazole, pH 7.4). The column fractions were monitored at 280 nm
and the desired fraction was concentrated by using a 10 kDa Macrosep centricon (Pall
Filtron) device before dialyzing against 6 L 50 mM HEPES and 300 mM NaCl (pH 7.5)
at 4 oC. The protein concentration was determined by the Bradford method and by
measuring the absorption at 280 nm ( = 56500 M-1 cm-1, and 41320 M-1 cm-1 for
PA5187 and PA5188 respectively) The protein purity was verified by SDS-PAGE
analysis.

4.2.5 PA3302 (R-specific Enoyl-CoA Hydratase) Gene Cloning and Expression in E.
coli and Recombinant Protein Purification (22)
The gene encoding the PA3302 (NCBI accession NP251992, Uni Prot accession:
Q9LBK2) was amplified by PCR from Pseudomonas aeruginosa PAO1 genomic DNA
and ligated into the pET-14b vector, which adds a His6 tag to the protein N-terminus.
Oligonucleotide primers of PA5187 containing restriction the endo-nuclease cleavage
sites NdeI and HindIII were used in the PCR reactions. Plasmid DNA was purified using
a Qiaprep Spin Miniprep Kit.
Gene expression was carried out in E. coli BL21(DE3) competent cells.
Following growth of the transformed cells for 6 h at 37 °C in 3 mL of LB media
containing 50 μg/mL Ampicillin, induction was initiated with the addition with 0.2 mM
isopropyl-1-thio-β-D-galactopyranoside. Following incubation for 12 h at 20 °C 170 rpm,
the cells were harvested by centrifugation (6500 rpm for 15 min at 4 °C), resuspended in
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50 mL of binding buffer (20 mM HEPES, 500 mM NaCl, 40 mM imidazole, pH 7.4) and
lysed by a single pass through a French Press cell (12,000 psi). The cells were removed
by centrifugation at 20,000 rpm for 45 min at 4 °C, and the supernatant containing
PA5187 was passed through a GE Histrap FF (1 mL) column pre-equilibrated with 5 CV
(25 mL) binding buffer (20 mM K+HEPES, 500 mM NaCl, and 40 mM imidazole, pH
7.4) at 4 oC. The column was first washed with 2 CV (10 mL) binding buffer and then
the PA5187 was eluted with 5 CV (25 mL) elution buffer (20 mM HEPES, 500 mM
NaCl, 500 mM imidazole, pH 7.4). The column fractions were monitored at 280 nm and
the desired fraction was concentrated by using a 10 kDa Macrosep centricon (Pall Filtron)
device before dialyzing against 6 L 50 mM HEPES and 300 mM NaCl (pH 7.5) at 4 oC.
The protein concentration was determined by the Bradford method and by measuring the
absorption at 280 nm. The protein purity was verified by SDS-PAGE analysis.

4.2.6 Purification of Recombinant S-specific Enoyl-CoA Hydratase
The clone of S-specific enoyl-CoA hydratase (from rat mitochondrial, NCBI
accession NP_511178, Uni Prot accession: P14604). The gene was ligated into pET-15b
vector, and expressed in E. coli (13). The clone was a gift from Professor Peter Tonge of
the State University of New York at Stony Brook. The transformed E. coli BL21(DE3)
cells were cultured with mixing (220 rpm) at 37 °C for 6 h grown in 3 L of LB media
containing 50 μg/mL Ampicillin before inducing with 0.2 mM isopropyl-1-thio-β-Dgalactopyranoside. After incubation for 12 h at 20 °C (mixing at 170 rpm), the cells were
harvested by centrifugation (6500 rpm for 15 min at 4 °C), resuspended in 50 mL of
binding buffer (20 mM HEPES, 500 mM NaCl, 40 mM imidazole, pH 7.4) and lysed by a
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single pass through a French Press cell (12,000 psi). The cell debri were removed by
centrifugation at 20,000 rpm for 45 min at 4 °C, and the supernatant containing Nterminal His6-tagged PA5187 was passed through a 1 mL GE Histrap FF pre-equilibrated
with 5 CV (25 mL) binding buffer (20 mM HEPES, 500 mM NaCl, 40 mM imidazole,
pH 7.4). The column was first washed with ? mL CV binding buffer (define) before
eluting with 2 CV (10 mL) elution buffer (20 mM HEPES, 500 mM NaCl, 500 mM
imidazole, pH 7.4). The column fractions were monitored at 280 nm and the desired
fraction was concentrated by using a 10 kDa Macrosep centricon (Pall Filtron) device
before dialyzing against 6 L 50 mM HEPES and 300 mM NaCl (pH 7.5) at 4 oC. The
protein concentration was determined by the Bradford method and by measuring the
absorption at 280 nm. The protein purity was verified by SDS-PAGE analysis.

4.2.7 Synthesis of trans-2,3-Alkenoyl-CoA Thioesters (C6, C8, C10)
The trans-2,3-hexenoyl-CoA, trans-2,3 octenoyl-CoA and trans-2,3-decenoyl-CoA were
synthesized using previous reported method (8). In a standard preparation, trans-2,3-hexenoic
acid, trans-2,3-octenoic acid or trans-2,3 decenoic acid (1 mmol) was dissolved in
tetrahydrofuran (2 mL), which have been freed of water and ether peroxides by distillation over
LiAlH4. The acids were neutralized with triethylamine (1.1 mmol) and allowed to react with ethyl
chloroformate (1.1 mmol). After 10 min at 25o the solution was rapidly filtered through a Pasteur
pipette containing a glasswool plug and then added dropwise over a period of 10 min to a solution
of CoA (Li+ salt; 40 µmol) dissolved in a mixture (5 mL) of water and tetrahydrofuran (3:2 v/v)
that had been adjusted to pH 8 by the addition of NaHCO3 (40 mg) and that had been purged with
N2. In order to optimize the yield of product, phase separation in the reaction mixture was
prevented by the addition of a few drops of water. After a total reaction time of 20 min, the pH of
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the reaction mixture was adjusted to approximately 3 and the tetrahydrofuran was removed by
evaporation under vacuum. The trans-2,3-hexenoyl-CoA and trans-2,3-octenoyl-CoA were used
without further purification after the excess alkanoic acid was removed by extraction with
pentane. The trans-2,3-decenoyl-CoA was purified by first precipitating it by saturating the crude
aqueous concentrate (pH 1) with NaCl and then collecting and washing the precipitate with
pentane.

The products were verified by mass spectral analysis. The observed m/z of trans-2,3hexenoyl-CoA, trans-2,3-octenoyl-CoA and trans-2,3-decenoyl-CoA are 860.3 (calct
859.1) 888.2 (calct 887.1), and 916.5 (calct 915.5)

respectively. which matches the

theoretical Mw of hexenoyl-CoA (859.1), octenoyl-CoA (887.1).

4.2.8 Enzyme Kinetics.

Activity Assays. Thioesterase activity was measured using the DTNP coupling assay. The
reaction solutions (1 mL) contained specified concentrations of substrate and 1 mM DTNB
in 0.15 M KCl and 50 mM K+HEPES (pH 7.5). The progress of the reaction was monitored
at 412 nm. The acyl-CoA dehydrogenase activity was measured at 600 nm by coupling
dihydroflavinadenine dinucleotide FADH2 formation to the reduction of 2,6-dichlorphenolindophenol (DCPIP) (19). The reaction solutions initially contained 50 mM K+HEPES (pH
7.5), a specified concentration of enzyme, 150 μM DCPIP, 100 μM phenazine
methosulphate (PMS) and 10 μM flavinadenine dinucleotide (FAD). The 3-hydroxyacylCoA dehydrogenase (PA5186) activity was measured by generating the S- or R-3hydroxyacyl-CoA substrate in situ by incubation of a specified concentation of the trans2,3-alkenoyl-CoA (vide infra) with 5 μM (S-specific) enoyl-CoA hydratase or 5 μM of the
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(R-specific) enoyl-CoA hydratase PA3302 in 0.5 mL of 50 mM K+HEPES for 5 min
before adding NAD to a final concentration of 0.5 mM. The reaction was initiated by the
addition of a small aliquot (20 L) of the 3-hydroxyacyl-CoA dehydrogenase (PA5188)
stock solution (0.5μM). The reaction progress was monitored at 340 nm.

Steady-state kinetic constant determinations. The initial velocity of the reaction was
measured as a function of the concentration of the substrate, varied in a range of 0.5 to 10fold KM. The initial velocity data were fitted with the enzyme kinetic module in Sigmaplot
to define Vmax and KM. The kcat was calculated from the ratio of Vmax and enzyme
concentration.
V = Vmax[S]/([S] + KM)
where V is the initial velocity, Vmax the maximum velocity, [S] the substrate
concentration, Km the Michaelis constant.

4.2.9 Size exclusion chromatography

Size exclusion column chromatography was performed at 4 oC on ÄKTA P-920
FPLC system and Hiprep 16/60 Sephacryl S-200 HR column (GE Healthcare) preequilibrated with 50 mM HEPES (pH 7.5), 500 mM NaCl, and 1 mM DTT. The column
was calibrated using the gel-filtration low molecular weight and high molecular weight
gel filtration calibration kit from Amersham Biosciences. Purified protein (2 mL, ca. 200
mM) was applied to the column.
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4.3 Results and Discussion
4.3.1 Comparison of the PA5185 X-ray Structure and Amino Acid Sequence to
Clade AA Hotdog-fold Thioesterases

Figure 4.1. Sequence alignment of PA5185 and five other clade AA homologues.
The X-ray structure of PA5185 was superimposed with the X-ray structures of these
hotdog-fold family members (PDB ID: 1LO8, 2OAF, 2ALI, 2FUJ, and 2CYE) using the
Dali structural alignment server. The structures 1LO8, 2OAF, 2ALI, 2FUJ, and 2CYE
share 14%, 19%, 31%, 28% and 28% sequence identity with BT3352 and have an RMSD
of 1.9, 1.7, 1.8, 1.7 Å and 2.1 Å, respectively. The figure was prepared using CLC
sequence viewer.

PA5185 belongs to the hotdog-fold superfamily of thioesterase. Despite the low
pair-wise sequence identity (see sequence alignment of structural homologues in Figure
4.3), the tertiary and quaternary structure of PA5185 (PDB 1BVQ) is quite similar to that
of the 4-hydroxybenzoyl-CoA (4-HB-CoA) thioesterase from Pseudomonas sp. strain
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CBS-3 (PDB 1LO8) (7), which is the prototype of the type AA clade of the hotdog-fold
thioesterases (7, 20, 21). The trait of the type AA clade is the utilization of the catalytic
Asp/Glu (nucleophile or general base) (loop) and Gly (at helix N-terminus; backbone
amide NH polarizes the thioester C=O) on the loop-helix catalytic motif of the same
subunit. The trait of the clade AB, the prototype of which is the Arthrobacter sp. strain
SU 4-HB-CoA thioesterase, is the utilization of the catalytic Asp/Glu from one subunit
(positioned on the helix of the loop-helix catalytic motif) and the catalytic Gly of the
helix N-terminus of the opposing subunit.

(a)

(b)
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A19 Y28
F13 W22
D17 D26
N32 N33
W23 Y24
D32 D41

W47 I56

T59 P60

(b)

(d)

Figure 4.2 (a) The Pymol-generated stereoview of the face-to-face tetramer of PA5185. The
subunits are colored individually to show the dimer units (blue and red; green and magenta). (b)
The Pymol generated stereoview of the superimposed active site residues of PA5185 (green) and
Pseudomonas 4-HB-CoA thioesterase (7) (gray). (c) The Pymol-generated stereoview of the
superimposed active site residues of PA5185 (green), Pseudomonas 4-HB-CoA thioesterase
(grey). (d) The Pymol-generated representations of the electrostatic topological features of
PA5185.

The superposition of the structures of PA5185 and the Pseudomonas 4-HB-CoA
thioesterase bound with the inhibitor 4-hydroxybenzyl-CoA show that the CoA binding site
residues Ile61, Phe68, Arg89, Lys90 and Ser91 in Pseudomonas 4-HB-CoA thioesterase
correspond to Val66, Tyr73, Asn93, Ser94 and Ser95 in PA5185 and thus, are not conserved.
Nevertheless, the surface topology (finger-like electropositive projection encircling the entrance
to catalytic site; Figure 4.4d) is consistent with the 4-HB-CoA thioesterase binding site for CoA
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(as opposed to ACP) thiol unit of the PA5185 acetyl/propionyl-CoA substrate (see following
section). The active site residues (with the exception of the catalytic Asp and Gly) of the two
thioesterases are also dissimilar. Moreover, the binding pocket for the 4-hydroxybenzoyl unit of
the 4-HB-CoA substrate in the 4-HB-CoA thioesterase is larger than the PA5185 binding pocket
for the acetyl/propionyl unit. This is consistent with PA5185 substrate specificity profile (see
following section).

4.3.2 Native molecular weight of PA5185

60.3 kDa

PA5185

Figure 4.3. The FPLC elution profile for the chromatography of recombinant PA5185 on a size
exclusion column, calibrated with protein molecular weight standards .

114

The oligomeric state of the PA5185 in solution was determined by size exclusion
chromatography (SEC), which defined a Native mass of 60.3 kDa (Figure 4.5 and Table
4.4). The mass spectral analysis of the PA5185 defined a subunit mass of 16744 Da,
which is consistent with the theoretical mass of 16745 Da. The ratio of the Native and
subunit masses of 3.6 suggests that PA5185 is a tetramer, which is consistent with its Xray structure.

4.3.3 PA5185 Substrate Specificity Profile
Purified PA5185 looses activity quickly (even when stored at -88 oC) and was
therefore subjected to substrate activity analysis soon after isolation. PA5185 exhibited
narrow substrate specificity, with only C2-C4 acyl-CoAs hydrolyzed. Propionyl-CoA is
the best substrate with Km= 24 µM, and kcat= 0.57 s-1 (kcat/Km = 2.4 x 104) (Figure 4.4a
and Table 4.1), followed by acetyl-CoA (kcat/Km = 1.6 x 103). Acetyl-CoA is the expected
end product of -oxidation of fatty acids of even carbon number (common form) whereas
propionyl-CoA would be generated by -oxidation of fatty acids of odd carbon number
(rare form). The 10-fold smaller Km value measured for the propionyl-CoA vs acetylCoA might be due to tighter binding of the propionyl group driven by the larger area for
desolvation. The acetyl-CoA is most likely the targeted substrate and the relatively large
Km value (160 M) is consistent with its role as a housekeeper in releasing CoA from
acetyl-CoA, a common metabolite, only in the event of its accumulation. PA5185 is very
sensitive to the carbon chain length of the substrate: the Km and kcat for malony-CoA,
butyryl-CoA and 3-hydroxybutyryl-CoA are 880 µM & 0.018 s-1, 320 µM & 0.082 s-1
and 180 µM & 0.036 s-1, respectively. Longer acyl-CoAs are not substrates and this
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critical for PA5185’s function in supporting the fatty acid -oxidation pathway proposed
below. The activity of propionyl-CoA thioesterase is modestly inhibited by the propionylCoA products CoASH (a competitive inhibitor Ki = 98 ± 8 M) and propionate (a
noncompetitive inhibitor Ki = 69 ± 7 M) (Figure 4.6b and c). The substrate analog 2keto-3-propanyl-CoA, was also found to be a competitive inhibitor vs propionyl-CoA: Ki
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0.015

Figure 4.4. Lineweaver-Burk plot of initial velocity data from (a). PA5185
catalyzed propionyl-CoA hydrolysis reaction in 50 mM HEPES (pH 7.5, 25 oC), (b) CoA
inhibition of PA5185 catalyzed propionyl-CoA hydrolysis, (c) propionate inhibition of
PA5185 catalyzed propionyl-CoA hydrolysis (d) 2-keto-3-propanyl-CoA inhibition of
PA5185 catalyzed propionyl-CoA hydrolysis.

Table 4.1. Steady-state kinetic constants measured for PA5185-catalyzed acylCoA metabolite thioester hydrolysis.
Km
kcat
(s-1)
(uM)
Short Chain Fatty Acyl-CoAs
(2.6 ± 0.1) x 10-1
(1.6 ± 0.1) x 102

Substrate
Acetyl-CoA

kcat/Km
(M-1s-1)
1.6 x 103

n-Propionyl-CoA

(5.7 ± 0.2) x 10

-1

(2.4 ± 0.1) x 10

2.4 x 104

Malonyl-CoA

(1.8 ± 0.1) x 10-2

(8.8 ± 0.9) x 102

2.0 x 10

(8.2 ± 0.2) x 10

-2

(3.2 ± 0.2) x 10

2

9.3 x 10

β-Hydroxybutyryl-CoA

(3.6 ± 0.1) x 10

-2

(1.8 ± 0.2) x 10

2

1.9 x 102

2-Butenoyl-CoA

< 1 x 10-4

--------

--------

Crotonyl-CoA

< 1 x 10-4

--------

--------

< 1 x 10

-4

--------

--------

< 1 x 10

-4

--------

--------

< 1 x 10

-4

--------

--------

< 1 x 10

-4

--------

--------

n-Butyryl-CoA

β-Methylcrotonyl-CoA
Tiglyl-CoA

n-Hexanoyl-CoA
n-Octanoyl-CoA

Medium-Long Chain Fatty Acyl-CoAs
Lauroyl-CoA
Myristoyl-CoA
n-Palmitoyl-CoA
Stearoyl-CoA

< 1 x 10-4

--------

--------

< 1 x 10

-4

--------

--------

< 1 x 10

-4

--------

--------

< 1 x 10

-4

--------

--------

Table 4.2. Steady-state kinetic constants measured for wild-type and mtuant
PA5185 catalyzed hydrolysis of n-propionyl-CoA in 50 mM HEPES (pH 7.5, 25 oC).
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-1

-1 -1

kcat (s )

Km (uM)

kcat/Km (M s )

WT

(5.7 ± 0.2) x 10-1

(2.4 ± 0.1) x 10

2.4 x 104

D26A

< 1 x 10-4

--------

--------

D26N

< 1 x 10-4

--------

--------

D41A

(1.5 ± 0.1) x 10-1

(3.7 ± 0.1) x 102

4.1x102

Site-directed mutagenesis was used to prepare catalytically inactive PA5185 for
future structure determination of the substrate-bound enzyme. Steady-state study showed
that both D26A and D26N were inactive in catalysis of propionyl-CoA (confirming the
role of Asp26 as the catalytic nucleophile or base, whereas the D41A mutant significant
retained activity (kcat/Km value of 4.1 x 102) (Table 4.2). D26A and D26N were both sent
to Dr Karen’s lab to carry out cocrystallization with propionyl-CoA.

4.3.4 Characterization of the Acyl-CoA Dehydrogenase PA5187.
To place the in vitro function of PA5185 in a biochemical context, its
“neighborhood” gene PA5187 was cloned, expressed and purified. Its genebank annotation
is “acyl-CoA dehydrogenase”. The acyl-CoA dehydrogenase activity of PA5187 was tested
against a series of acy-CoA metabolites (Table 4.3; Figure 4.7). PA5187 showed wide
activity over C4 to C14 chain acyl-CoA substrates with decant catalytic efficiency. The
kcat/Km value varied from 103 M-1 s-1 to 104 M-1 s-1. The best substrate for PA5187 is nhexanoyl-CoA, with Km=15 µM, kcat= 0.5 s-1, and kcat/Km = 3.3 x104 M-1 s-1. The Km value
did not vary much although lauroyl-CoA did have the lowest Km=9.2 µM. The kcat value is
more sensitive to the elongation of substrate’s carbon chain. The maximum kcat value was
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observed for C6 to C8 acyl-CoAs. Overall, the largest substrate specificity constants
(kcat/Km) were obsrved for medium chain length acyl-CoAs, thus suggesting that PA5187
partners with PA5185 in the -oxidation of medium chain length fatty acids.
The native PA5187 in solution was determined by size exclusion chromatography
to be ~152 kDa compared to the subunit mass of 66601 determined by mass spectral
analysis (Figure 4.3a and Table 4.4), thus defining the protein as dimer in solution.
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Figure 4.5. Lineweaver-Burk plot of the initial velocity data from (a). PA5187
catalyzed dehydrogenation of hexanoyl-CoA in 50 mM HEPES (pH 7.5, 25 oC), and (b).
PA5188 catalyzed dehydrogenation of S-specific 3-hydroxylhexanoyl-CoA in 50 mM
HEPES (pH 7.5, 25 oC)

Table 4.3. Steady-state kinetic constants determined for PA5187 acyl-CoA
dehydrogenase. All data are obtained at 25 oC, 50 mM HEPES buffer pH 7.5. DCPIP (2,6
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dichlorophenol indophenols), PMS (Phenazine methosulphate) and FAD

were used

coupling system.

n-butyryl-CoA

kcat
(s-1)
(8.8 ± 0.6) x 10-2

Km
(uM)
(3.0 ± 0.2) x 10

kcat/Km
(M-1s-1)
3.0x103

n-hexanoyl-CoA

(5.0 ± 0.1) x 10-1

(1.5 ± 0.1) x 10

3.3x104

n-octanoyl-CoA

(5.1 ± 0.1) x 10

-1

(2.1 ± 0.2) x 10

2.3x104

n-decanoyl-CoA

(2.8 ± 0.2) x 10-1

(6.8 ± 0.7) x 10

4.1x103

Lauroyl-CoA

(1.2 ± 0.1) x 10-1

9.2 ± 0.8

1.4x104

Myristoyl-CoA

(8.0 ± 0.3) x 10-2

(1.1 ± 0.1) x 10

8.0x103

n-Palmitoyl-CoA

< 1 x 10-4

--------

--------

Palmitoleoyl-CoA

(6.8 ± 0.2) x 10-2

(8.9 ± 0.9) x 10

7.8x102

Stearoyl-CoA

< 1 x 10-4

--------

--------

< 1 x 10

-4

--------

--------

< 1 x 10

-4

--------

--------

< 1 x 10

-4

--------

--------

Substrate

Oleoyl-CoA
Linoleoyl-CoA
Arachidonyl-CoA

41.5 kDa (0.9 x 45.1 kDa)
152.2 kDa (2.3 x 64.8 kDa)

PA5187

(a)

PA5188

(b)

Figure 4.6. SEC of recombinant expressed and purified proteins (a) PA5187; (b) PA5188.
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Table 4.4. Size exclusion chromatography evaluation table

Enzymes

Monomer
Mw, calc (kDa)
Mw, obs (kDa)

Sec
x-merobs

Oligomer

PA5185

16.7

60.3

3.6

Tetramer

PA5187

64.8

152.2

2.3

Dimer

PA5188

45.1

41.5

0.9

Monomer

4.3.5 Charaterization of the 3-hydroxyacyl-CoA dehydrogenase PA5188.
Another PA5185 “neighborhood” protein PA5188 is annotated as 3-hydroxyacylCoA dehydrogenase. It is the third enzymes in beta oxidation cycle following the enoyl –
CoA hydratase. The mass spectral analysis of the PA5188 shows that the Mw of the
protein is 45089.4 Da. It matches perfectly with the theoretical Mw of 45088.1 Da,
computed by ExPASy. PA5188 is not very stable, and it will automatically precipitate in
room temperature, so thrombin was used to remove the histag at 4 °C overnight. The
oligomeric state of the PA5188 in solution was determined by size exclusion
chromatography too. In the solution used (50 mM Hepes, 500 mM NaCl, 1 mM DTT),
PA5188 stay as monomer. SEC results showed a calculated molecular weight at about
41.5 kDa (figure 4.3b and table 4.4), which is 0.9 times less than the monomer molecular
weight showed by mass spectral analysis(45.1 kDa).

Table 4.5. PA5188 putative beta hydroxyacyl-CoA dehydrogenase substrate screen table.
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All data are obtained at 25 oC, 50 mM Hepes buffer pH=7.5. Echs was used as coenzyme
to product s-specific 3-hydrxoyacyl-CoA, and the increase of absorbance at 340 nm was
monitored by UV-Vis spectrometer.
Substrate
(S) 3-hydroxybutyryl-CoA
(R) 3-hydroxybutyryl-CoA
(S) 3-hydroxyhexanoyl-CoA
(R) 3-hydroxyhexanoyl-CoA
(S) 3-hydroxyoctanoyl-CoA
(R) 3-hydroxyoctanoyl-CoA
(S) 3-hydroxydecanoyl-CoA
(R) 3-hydroxydecanoyl-CoA

kcat

Km

kcat/Km

(s )

(µM)

(M s )

(1.6 ± 0.1) x 10-1
< 1 x 10-4

(3.5 ± 0.1) x 102
--------

4.5 x 10
--------

4.5 ± 0.3
< 1 x 10-4

(1.2 ± 0.1) x 10
--------

3.8 x 10
--------

(7.5 ± 0.3) x 10-1
< 1 x 10-4

(9.8 ± 1.0) x 10
--------

7.6 x 10
--------

(7.4 ± 0.2) x 10-2
< 1 x 10-4

(2.0 ± 0.2) x 102
--------

3.8 x 10
--------

-1

-1 -1

2

5

3

2

The kinetic data of PA5188 was evaluated by enoyl-CoA hydratase assisted
coupling assay. Enoyl-CoA hydratase is the second enzyme in the beta-oxidation cycle, it
convert the enoyl-CoA, which is the protduct of acyl-CoA dehydrogenase, to 3hydroxyacyl-CoA. The S-specific coupling enzyme echs1 is a gift from Dr Tonge’ lab at
SUNY, while the R-specific enoyl-CoA hydratase, PhaJ1PA (22), was cloned from
Pseudomonas aeruginosa PAO1, and purified with histag. The trans hexenoyl-CoA,
octenoyl-CoA and decenoyl-CoA were organic synthesized from trans hexenoic acid,
octenoic acid and decenoic acid respectively, and the substrates were confirmed by mass
spectral. The kinetic substrate screen data was shown on table 4.5. PA5188 showed very
high activity over S-specific 3-hydroxyhexanoyl-CoA, kcat=4.5 s-1 and Km= 12 µM and
kcat/Km= 3.8 x 105 M-1 s-1. The smaller substrate, 3-hydroxybutyryl-CoA, and longer
substrate, 3-hydroxydecanoyl-CoA, both bind much less tightly to PA5188 than 3122

hydroxyhexanoyl-CoA with Km value of 350 µM and 200 µM respectively. PA5188
showed decant activity over another medium long chain substrate 3-hydroxyoctanoylCoA, with 8 times greater Km and 6 fold slower rate than 3-hydroxyhexanoyl-CoA.
PA5188 seems to be very “S-specific” protein. It cannot recognize all the R-specific
substrates, which testified that it is involved in the beta oxidation pathway.

4.5 Conclusion
Hot dog fold thioesterase PA5185 act as a “house keeper” protein to regulate the
level of propionyl-CoA and release propionate and CoA. PA5185 is a very specific
thioesterase, and it only good for very short chain fatty acyl-CoA, such as acetyl-CoA,
propionyl-CoA and butyryl-CoA. Its tiny active site may make CoASH as a good
inhibitor for the protein. This may explain the slow turn over number of propionyl-CoA.
Together with the propionyl-CoA is ending metabolite of beta oxidation pathway, we
hypothesize this thioesterase may act as a “house keeper”, it can be expressed when
CoASH is in low level, and be stopped when CoASH resumed or even act as a regulator
for beta oxidation pathway and other propionyl-CoA related pathway. PA5187 catalyze
the dehydrogation of short chain to median long chain acyl-CoA. It exhibit wild substrate
specificities, which may works on both even number fatty acyl-CoAs and odd number
fatty acyl-CoAs to degrade them to propionyl-CoA and acetyl-CoA as end product. The
PA5188 converts exclusively S-specific 3-hydroxyacyl CoA instead of R-specific
substrate to 3-ketoacyl CoA for further degradation. Based on these results, the three
target protein, PA5185, PA5187 and PA5188, may belong to the beta oxidation pathway.
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There are still a lot of works need to be down to investigate the function and
mechanism of PA5185. Enzyme-ligand complex is needed to further analysis the
substrate binding, the mechanism of reaction, and product release, this is essential to
better understanding how PA5185 sense the level of CoASH, and how it regulate the
other pathway. To verify these proteins biological functions, the putative iron containing
alcohol dehydrogenase need to be investigated. Because, there is no room for PA5186 in
beta oxidation pathway, it is very possible that this protein is related to the downstream
pathway that start from propionyl-CoA.
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